Fourth Quarter and Full Year 2014 Results
|
Content
|
|||
HIGHLIGHTS
|
3
|
||
COMMENTS FROM THE CEO, ILKER KURUOZ
|
4
|
||
FINANCIAL AND OPERATIONAL REVIEW
|
|||
FINANCIAL REVIEW OF TURKCELL GROUP
|
6
|
||
OPERATIONAL REVIEW IN TURKEY
|
11
|
||
OTHER DOMESTIC AND INTERNATIONAL OPERATIONS
|
|||
ASTELIT
|
11
|
||
TURKCELL SUPERONLINE
|
12
|
||
FINTUR
|
13
|
||
TURKCELL GROUP SUBSCRIBERS
|
14
|
||
OVERVIEW OF THE MACROECONOMIC ENVIRONMENT
|
15
|
||
RECONCILIATION OF NON-GAAP FINANCIAL MEASUREMENTS
|
16
|
·
|
Please note that all financial data is consolidated and comprises that of Turkcell Iletisim Hizmetleri A.S., (the “Company”, or “Turkcell”) and its subsidiaries and associates (together referred to as the “Group”). All non-financial data is unconsolidated and comprises Turkcell only figures. The terms “we”, “us”, and “our” in this press release refer only to the Company, except in discussions of financial data, where such terms refer to the Group, and where context otherwise requires.
|
·
|
In this press release, year-on-year comparison of our key indicators is provided and figures in parentheses following the operational and financial results for the year end 2014 refer to the same item at the year end of 2013 and figures in parentheses following the operational and financial results for the fourth quarter of 2014 refer to the same item in the fourth quarter of 2013. For further details, please refer to our consolidated financial statements and notes as at and for the year ended December 31, 2014, which can be accessed via our website in the investor relations section (www.turkcell.com.tr).
|
·
|
Please note that selected financial information presented in this press release for the fourth quarters and year end of 2014 and 2013, both in TRY and US$ is based on IFRS figures.
|
·
|
In the tables used in this press release totals may not foot due to rounding differences. The same applies for the calculations in the text.
|
Fourth Quarter and Full Year 2014 Results
|
·
|
Turkcell Group revenues and EBITDA1 both grew by 6% to TRY12,044 million (TRY11,408 million) and TRY3,762 million (TRY3,544 million), respectively. EBITDA margin was at 31.2% (31.1%).
|
·
|
Net income fell 20% to TRY1,865 million (TRY2,326 million), adversely impacted mainly by macroeconomic conditions in our international markets of operation as well as several one off items. Excluding the one-off items, net income would be TRY2,135 million2.
|
·
|
Mobile business revenues in Turkey rose 3% to TRY9,369 million (TRY9,123 million) with an EBITDA margin of 31.2% (31.0%).
|
|
o
|
Mobile broadband revenues grew by 34% to TRY1,931 million (TRY1,437 million) with strong demand for data.
|
|
o
|
Voice revenues3 fell by 1% to TRY6,374 million (TRY6,460 million), mainly due to lower MTRs.
|
·
|
Subsidiaries4 registered revenue growth of 17% to TRY2,674 million (TRY2,285 million) and EBITDA growth of 18% to TRY838 million (TRY712 million).
|
·
|
On January 28, 2015, Turkcell announced CEO, Sureyya Ciliv’s resignation. On the same day, the Turkcell Board of Directors appointed Ilker Kuruoz as acting CEO in addition to his role as the Chief Technology Group Officer.
|
·
|
Group revenues grew by 8% to TRY3,103 million (TRY2,884 million) with the higher contribution of mobile broadband and fiber broadband revenues.
|
·
|
Group EBITDA1 rose 8% to TRY917 million (TRY851 million) with an EBITDA margin of 29.6% (29.5%).
|
·
|
Net income fell by 49% to TRY258 million (TRY505 million), mainly due to currency devaluation in Ukraine and Belarus, along with various one-offs. Excluding one-off impacts, net income would be TRY390 million2.
|
·
|
Mobile business revenues in Turkey reached TRY2,392 million (TRY2,240 million) on 7% growth, while the EBITDA margin rose to 30.1% (29.9%).
|
|
o
|
Mobile broadband revenues rose by 44% to TRY567 million (TRY394 million), posting the highest growth rate of the year.
|
|
o
|
Voice revenues3 grew by 1% to TRY1,555 million (TRY1,547 million).
|
·
|
Revenues of subsidiaries4 climbed 10% to TRY711 million (TRY644 million) with an EBITDA increase of 8% to TRY196 million (TRY181 million).
|
Fourth Quarter and Full Year 2014 Results
|
Fourth Quarter and Full Year 2014 Results
|
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Profit & Loss Statement
(million TRY)
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Total Revenue
|
2,883.6 | 3,103.2 | 7.6 | % | 11,407.9 | 12,043.6 | 5.6 | % | ||||||||||||||||
Direct cost of revenues1
|
(1,851.3 | ) | (1,972.2 | ) | 6.5 | % | (7,063.9 | ) | (7,383.9 | ) | 4.5 | % | ||||||||||||
Direct cost of revenues1/revenues
|
(64.2 | %) | (63.6 | %) |
0.6pp
|
(61.9 | %) | (61.3 | %) |
0.6pp
|
||||||||||||||
Depreciation and amortization
|
(481.6 | ) | (450.7 | ) | (6.4 | %) | (1,594.4 | ) | (1,639.4 | ) | 2.8 | % | ||||||||||||
Gross Margin
|
35.8 | % | 36.4 | % |
0.6pp
|
38.1 | % | 38.7 | % |
0.6pp
|
||||||||||||||
Administrative expenses
|
(152.0 | ) | (146.8 | ) | (3.4 | %) | (550.3 | ) | (562.7 | ) | 2.3 | % | ||||||||||||
Administrative expenses/revenues
|
(5.3 | %) | (4.7 | %) |
0.6pp
|
(4.8 | %) | (4.7 | %) |
0.1pp
|
||||||||||||||
Selling and marketing expenses
|
(510.4 | ) | (517.8 | ) | 1.4 | % | (1,843.6 | ) | (1,974.6 | ) | 7.1 | % | ||||||||||||
Selling and marketing expenses/revenues
|
(17.7 | %) | (16.7 | %) |
1.0pp
|
(16.2 | %) | (16.4 | %) |
(0.2pp
|
) | |||||||||||||
EBITDA2
|
851.5 | 917.1 | 7.7 | % | 3,544.5 | 3,761.8 | 6.1 | % | ||||||||||||||||
EBITDA Margin
|
29.5 | % | 29.6 | % |
0.1pp
|
31.1 | % | 31.2 | % |
0.1pp
|
||||||||||||||
EBIT3
|
369.9 | 466.4 | 26.1 | % | 1,950.1 | 2,122.4 | 8.8 | % | ||||||||||||||||
Net finance income / (expense)
|
149.7 | (176.9 | ) | (218.2 | %) | 555.3 | (291.6 | ) | (152.5 | %) | ||||||||||||||
Finance expense
|
(89.7 | ) | (400.1 | ) | 346.0 | % | (204.6 | ) | (1,247.0 | ) | 509.5 | % | ||||||||||||
Finance income
|
239.4 | 223.2 | (6.8 | %) | 759.9 | 955.4 | 25.7 | % | ||||||||||||||||
Share of profit of associates
|
75.8 | (6.9 | ) | (109.1 | %) | 297.3 | 207.3 | (30.3 | %) | |||||||||||||||
Other income / (expense)
|
(35.6 | ) | 1.4 | (103.9 | %) | (58.9 | ) | (76.3 | ) | 29.5 | % | |||||||||||||
Monetary gains / (losses)
|
72.5 | 32.3 | (55.4 | %) | 176.9 | 205.1 | 15.9 | % | ||||||||||||||||
Non-controlling interests
|
(7.9 | ) | 128.9 |
n.m.
|
(3.4 | ) | 428.2 |
n.m.
|
||||||||||||||||
Income tax expense
|
(119.5 | ) | (187.3 | ) | 56.7 | % | (591.4 | ) | (730.4 | ) | 23.5 | % | ||||||||||||
Net Income
|
504.9 | 257.9 | (48.9 | %) | 2,325.9 | 1,864.7 | (19.8 | %) |
|
·
|
6.8% rise in mobile business revenues in Turkey to TRY2,391.7 million (TRY2,239.5 million)
|
|
-
|
43.9% growth in mobile broadband revenues to TRY566.7 million (TRY393.7 million) with increased smartphone users on our network, higher number of mobile broadband users and increased data usage
|
Fourth Quarter and Full Year 2014 Results
|
|
-
|
25.7% fall in SMS revenues due to the declining usage trend impacted by the adoption of OTT (“over the top” messaging) and other alternative instant messaging services, coupled with the ICTA’s 20% ceiling price decrease on SMS, which came into effect on 1 January 2014
|
|
-
|
20.7% increase in mobile services revenues with our increased efforts to promote these services
|
|
·
|
10.5% increase in the revenues of subsidiaries to TRY711.4 million (TRY644.0 million) comprising 22.9% (22.3%) of the Group top line.
|
|
-
|
28.1% increase in Turkcell Superonline revenues to TRY335.8 million (TRY262.1 million)
|
|
-
|
27.9% decline in Astelit’s revenues to TRY167.1 million (TRY231.9 million)
|
|
·
|
2.7% increase in mobile business revenues in Turkey to TRY9,369.5 million (TRY9,123.1 million). Excluding MTR cut impact, mobile business revenues in Turkey would have increased by 5%.
|
|
-
|
34.4% rise in mobile broadband revenues to TRY1,930.6 million (TRY1,436.7 million) with increased smartphone penetration of 10 percentage points in a year, a higher number of mobile broadband users and increased data usage
|
|
-
|
23.0% fall in SMS revenues due to the declining usage trend impacted by the increasing adoption of OTT and alternative messaging services, coupled with the ICTA’s 20% ceiling price decrease on SMS
|
|
-
|
5.3% growth in mobile services revenues
|
|
·
|
17.0% rise in the revenues of subsidiaries to TRY2,674.1 million (TRY2,284.7 million) constituting 22.2% (20.0%) of the Group top line.
|
|
-
|
35.4% growth in Turkcell Superonline revenues to TRY1,252.5 million (TRY925.2 million)
|
|
-
|
12.0% decrease in Astelit’s revenues to TRY758.2 million (TRY861.6 million)
|
Quarter
|
Year
|
|||||||||||||||||||||||
Million TRY
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Interconnect revenues
|
253.2 | 281.3 | 11.1 | % | 1,171.3 | 1,116.5 | (4.7 | %) | ||||||||||||||||
as a % of revenues
|
11.3 | % | 11.8 | % |
0.5pp
|
12.8 | % | 11.9 | % |
(0.9pp
|
) | |||||||||||||
Interconnect costs
|
(238.6 | ) | (267.1 | ) | 11.9 | % | (1,118.3 | ) | (1,049.7 | ) | (6.1 | %) | ||||||||||||
as a % of revenues
|
(10.7 | %) | (11.2 | %) |
(0.5pp
|
) | (12.3 | %) | (11.2 | %) |
1.1pp
|
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Million TRY
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Turkcell Turkey
|
21.9 | 72.9 | 232.9 | % | 139.1 | 225.8 | 62.3 | % | ||||||||||||||||
Turkcell Superonline
|
(18.4 | ) | (6.3 | ) | (65.8 | %) | (59.2 | ) | (38.2 | ) | (35.5 | %) | ||||||||||||
Astelit
|
(2.3 | ) | (294.9 | ) |
n.m.
|
(7.6 | ) | (991.2 | ) |
n.m.
|
||||||||||||||
Best
|
(58.9 | ) | (149.6 | ) | 154.0 | % | (123.6 | ) | (294.5 | ) | 138.3 | % | ||||||||||||
Other
|
(1.3 | ) | (5.1 | ) | 292.3 | % | (24.3 | ) | (12.7 | ) | (47.7 | %) | ||||||||||||
Turkcell Group
|
(59.0 | ) | (383.0 | ) | 549.2 | % | (75.6 | ) | (1,110.8 | ) |
n.m.
|
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Million TRY
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Current Tax expense
|
(166.7 | ) | (170.3 | ) | 2.2 | % | (650.5 | ) | (709.4 | ) | 9.1 | % | ||||||||||||
Deferred Tax Income/expense
|
47.2 | (17.0 | ) | (136.0 | %) | 59.1 | (21.0 | ) | (135.5 | %) | ||||||||||||||
Income Tax expense
|
(119.5 | ) | (187.3 | ) | 56.7 | % | (591.4 | ) | (730.4 | ) | 23.5 | % |
Net income impacts (million TRY)
|
Q413
|
FY13
|
Net income impacts (million TRY)
|
Q414
|
FY14
|
|
Net income excluding one-offs*
|
630
|
2,511
|
Net income excluding one-offs*
|
390
|
2,135
|
|
BeST impairment
|
(61)
|
(61)
|
Best impairment
|
(35)
|
(35)
|
|
ICTA Decision Regarding a Tariff**
|
(41)
|
(41)
|
Fintur impact
|
(83)
|
(116)
|
|
Other impacts
|
(23)
|
(83)
|
A-Tel Share Sale impact
|
-
|
24
|
|
Reimbursements**
|
(8)
|
(29)
|
||||
ICTA penalties**
|
(2)
|
(108)
|
||||
Other impacts
|
(4)
|
(6)
|
||||
Net income reported
|
505
|
2,326
|
Net income reported
|
258
|
1,865
|
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||
Consolidated Cash Flow (million TRY)
|
Q413 | Q414 |
FY13
|
FY14
|
||||||||||||
EBITDA1
|
851.5 | 917.1 | 3,544.5 | 3,761.8 | ||||||||||||
LESS:
|
||||||||||||||||
Capex and License
|
(818.5 | ) | (935.3 | ) | (1,822.3 | ) | (2,144.8 | ) | ||||||||
Turkcell
|
(500.2 | ) | (593.7 | ) | (1,057.8 | ) | (1,361.6 | ) | ||||||||
Turkcell Superonline
|
(172.1 | ) | (254.4 | ) | (399.1 | ) | (552.8 | ) | ||||||||
Ukraine2
|
(61.2 | ) | (37.7 | ) | (144.6 | ) | (101.3 | ) | ||||||||
Net interest Income/ (expense)
|
208.7 | 206.1 | 630.9 | 819.3 | ||||||||||||
Other
|
199.1 | 57.8 | (995.2 | ) | (1,633.8 | ) | ||||||||||
Net Change in Debt
|
(15.2 | ) | 94.2 | (227.9 | ) | 100.5 | ||||||||||
Cash generated / (used)
|
425.6 | 339.9 | 1,130.0 | 903.0 | ||||||||||||
Cash balance
|
8,128.9 | 9,031.9 | 8,128.9 | 9,031.9 |
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Summary of Operational Data
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Number of total subscribers (million)
|
35.2 | 34.6 | (1.7 | %) | 35.2 | 34.6 | (1.7 | %) | ||||||||||||||||
Postpaid
|
14.0 | 15.2 | 8.6 | % | 14.0 | 15.2 | 8.6 | % | ||||||||||||||||
Prepaid
|
21.2 | 19.4 | (8.5 | %) | 21.2 | 19.4 | (8.5 | %) | ||||||||||||||||
ARPU(Average Monthly Revenue per User), blended (TRY)
|
21.3 | 23.0 | 8.0 | % | 21.7 | 22.5 | 3.7 | % | ||||||||||||||||
Postpaid
|
36.5 | 38.0 | 4.1 | % | 37.3 | 37.7 | 1.1 | % | ||||||||||||||||
Prepaid
|
11.3 | 11.6 | 2.7 | % | 11.8 | 11.6 | (1.7 | %) | ||||||||||||||||
ARPU, blended (US$)
|
10.5 | 10.3 | (1.9 | %) | 11.4 | 11.2 | (1.8 | %) | ||||||||||||||||
Postpaid
|
18.0 | 17.0 | (5.6 | %) | 19.6 | 18.8 | (4.1 | %) | ||||||||||||||||
Prepaid
|
5.6 | 5.2 | (7.1 | %) | 6.2 | 5.8 | (6.5 | %) | ||||||||||||||||
Churn (%)
|
6.7 | % | 7.7 | % |
1.0pp
|
27.4 | % | 28.3 | % |
0.9pp
|
||||||||||||||
MOU (Average Monthly Minutes of Usage per Subscriber), blended
|
257.5 | 279.3 | 8.5 | % | 259.3 | 275.3 | 6.2 | % |
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Astelit*
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Number of subscribers (million)1
|
12.6 | 13.9 | 10.3 | % | 12.6 | 13.9 | 10.3 | % | ||||||||||||||||
Active (3 months)2
|
9.2 | 10.3 | 12.0 | % | 9.2 | 10.3 | 12.0 | % | ||||||||||||||||
MOU (minutes) (12 months)
|
172.0 | 162.8 | (5.3 | %) | 179.0 | 166.7 | (6.9 | %) | ||||||||||||||||
ARPU (Average Monthly Revenue per User), blended (US$)
|
3.1 | 1.8 | (41.9 | %) | 3.2 | 2.2 | (31.3 | %) | ||||||||||||||||
Active (3 months) (US$)
|
4.1 | 2.4 | (41.5 | %) | 4.3 | 3.0 | (30.2 | %) | ||||||||||||||||
Active (3 months) (UAH)
|
32.9 | 33.3 | 1.2 | % | 34.4 | 34.5 | 0.3 | % | ||||||||||||||||
Revenue (million UAH)
|
912.8 | 1,046.7 | 14.7 | % | 3,595.2 | 4,051.7 | 12.7 | % | ||||||||||||||||
Revenue (million TRY)
|
231.9 | 167.1 | (27.9 | %) | 861.6 | 758.2 | (12.0 | %) | ||||||||||||||||
Revenue (million US$)
|
114.2 | 74.5 | (34.8 | %) | 449.8 | 347.2 | (22.8 | %) | ||||||||||||||||
EBITDA (million UAH)
|
281.0 | 310.4 | 10.5 | % | 1,096.0 | 1,237.3 | 12.9 | % | ||||||||||||||||
EBITDA (million TRY)
|
71.4 | 49.7 | (30.4 | %) | 262.9 | 232.2 | (11.7 | %) | ||||||||||||||||
EBITDA (million US$)3
|
35.2 | 22.2 | (36.9 | %) | 137.1 | 106.3 | (22.5 | %) | ||||||||||||||||
EBITDA margin
|
30.8 | % | 29.7 | % |
(1.1pp
|
) | 30.5 | % | 30.6 | % |
0.1pp
|
|||||||||||||
Net loss (million UAH)
|
(19.1 | ) | (2,078.7 | ) |
n.m.
|
(261.5 | ) | (5,593.2 | ) |
n.m.
|
||||||||||||||
Net loss (million TRY)
|
(4.9 | ) | (323.2 | ) |
n.m.
|
(60.7 | ) | (1,066.9 | ) |
n.m.
|
||||||||||||||
Net loss (million US$)
|
(2.4 | ) | (145.0 | ) |
n.m.
|
(32.7 | ) | (484.3 | ) |
n.m.
|
||||||||||||||
Capex (million UAH)
|
213.9 | 327.2 | 53.0 | % | 541.5 | 688.9 | 27.2 | % | ||||||||||||||||
Capex (million TRY)
|
61.2 | 37.7 | (38.4 | %) | 144.6 | 101.3 | (29.9 | %) | ||||||||||||||||
Capex (million US$)
|
26.8 | 15.8 | (41.0 | %) | 67.8 | 43.7 | (35.5 | %) |
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Turkcell Superonline* (million TRY)
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Revenue
|
262.1 | 335.8 | 28.1 | % | 925.2 | 1,252.5 | 35.4 | % | ||||||||||||||||
Residential
|
94.4 | 144.2 | 52.8 | % | 329.6 | 504.9 | 53.2 | % | ||||||||||||||||
% of revenues
|
36.0 | % | 42.9 | % |
6.9pp
|
35.6 | % | 40.3 | % |
4.7pp
|
||||||||||||||
Corporate
|
73.7 | 93.9 | 27.4 | % | 253.4 | 335.1 | 32.2 | % | ||||||||||||||||
% of revenues
|
28.1 | % | 28.0 | % |
(0.1pp
|
) | 27.4 | % | 26.8 | % |
(0.6pp
|
) | ||||||||||||
Wholesale
|
94.0 | 97.7 | 3.9 | % | 342.3 | 412.5 | 20.5 | % | ||||||||||||||||
% of revenues
|
35.9 | % | 29.1 | % |
(6.8pp
|
) | 37.0 | % | 32.9 | % |
(4.1pp
|
) | ||||||||||||
EBITDA 3
|
64.1 | 86.0 | 34.2 | % | 237.8 | 327.1 | 37.6 | % | ||||||||||||||||
EBITDA Margin
|
24.4 | % | 25.6 | % |
1.2pp
|
25.7 | % | 26.1 | % |
0.4pp
|
||||||||||||||
Capex
|
172.1 | 254.4 | 47.8 | % | 399.1 | 552.8 | 38.5 | % | ||||||||||||||||
FTTH subscribers
|
570.0 | 735.1 | 29.0 | % | 570.0 | 735.1 | 29.0 | % |
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Fintur*
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
Subscribers (million)
|
21.5 | 20.8 | (3.3 | %) | 21.5 | 20.8 | (3.3 | %) | ||||||||||||||||
Kazakhstan
|
14.3 | 13.0 | (9.1 | %) | 14.3 | 13.0 | (9.1 | %) | ||||||||||||||||
Azerbaijan
|
4.4 | 4.6 | 4.5 | % | 4.4 | 4.6 | 4.5 | % | ||||||||||||||||
Moldova
|
1.0 | 1.1 | 10.0 | % | 1.0 | 1.1 | 10.0 | % | ||||||||||||||||
Georgia
|
1.8 | 2.1 | 16.7 | % | 1.8 | 2.1 | 16.7 | % | ||||||||||||||||
Revenue (million US$)
|
527 | 423 | (19.7 | %) | 2,036 | 1,801 | (11.5 | %) | ||||||||||||||||
Kazakhstan
|
322 | 248 | (23.0 | %) | 1,233 | 1,052 | (14.7 | %) | ||||||||||||||||
Azerbaijan
|
151 | 127 | (15.9 | %) | 584 | 549 | (6.0 | %) | ||||||||||||||||
Moldova
|
20 | 17 | (15.0 | %) | 79 | 72 | (8.9 | %) | ||||||||||||||||
Georgia
|
35 | 31 | (11.4 | %) | 140 | 128 | (8.6 | %) | ||||||||||||||||
Fintur’s contribution to Group’s net income (million US$)
|
37 | (3 | ) | (108.1 | %) | 156 | 95 | (39.1 | %) |
Turkcell Group Subscribers (million)
|
2013
|
2014
|
y/y% | ||||||||||
Turkcell Turkey
|
35.2 | 34.6 | (1.7 | %) | |||||||||
Ukraine
|
12.6 | 13.9 | 10.3 | % | |||||||||
Fintur
|
21.5 | 20.8 | (3.3 | %) | |||||||||
Northern Cyprus
|
0.4 | 0.4 | - | ||||||||||
Belarus
|
1.2 | 1.4 | 16.7 | % | |||||||||
Turkcell Europe1
|
0.4 | 0.4 | - | ||||||||||
TURKCELL GROUP
|
71.3 | 71.5 | 0.3 | % |
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | |||||||||||||||||||
TRY / US$ rate
|
||||||||||||||||||||||||
Closing Rate
|
2.1343 | 2.3189 | 8.6 | % | 2.1343 | 2.3189 | 8.6 | % | ||||||||||||||||
Average Rate
|
2.0302 | 2.2421 | 10.4 | % | 1.9094 | 2.1850 | 14.4 | % | ||||||||||||||||
Consumer Price Index (Turkey)
|
2.3 | % | 1.6 | % |
(0.7pp)
|
7.4 | % | 8.2 | % |
0.8pp
|
||||||||||||||
GDP Growth (Turkey)
|
4.5 | % |
n.a.
|
n.a.
|
4.1 | % |
n.a.
|
n.a.
|
||||||||||||||||
UAH/ US$ rate
|
||||||||||||||||||||||||
Closing Rate
|
7.99 | 15.77 | 97.4 | % | 7.99 | 15.77 | 97.4 | % | ||||||||||||||||
Average Rate
|
7.99 | 14.09 | 76.3 | % | 7.99 | 11.87 | 48.6 | % | ||||||||||||||||
BYR/ US$ rate
|
||||||||||||||||||||||||
Closing Rate
|
9,510 | 11,850 | 24.6 | % | 9,510 | 11,850 | 24.6 | % | ||||||||||||||||
Average Rate
|
9,282 | 10,912 | 17.6 | % | 8,883 | 10,255 | 15.4 | % |
Fourth Quarter and Full Year 2014 Results
|
Quarter
|
Year
|
|||||||||||||||||||||||
Turkcell Group (million US$)
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
EBITDA
|
420.4 | 409.1 | (2.7 | %) | 1,858.0 | 1,725.2 | (7.1 | %) | ||||||||||||||||
Income tax expense
|
(59.4 | ) | (83.5 | ) | 40.6 | % | (310.7 | ) | (334.6 | ) | 7.7 | % | ||||||||||||
Other operating income / (expense)
|
(16.9 | ) | (1.3 | ) | (92.3 | %) | (29.2 | ) | (40.3 | ) | 38.0 | % | ||||||||||||
Financial income / (expense)
|
78.2 | 3.9 | (95.0 | %) | 299.9 | 17.8 | (94.1 | %) | ||||||||||||||||
Net increase / (decrease) in assets and liabilities
|
26.5 | 14.9 | (43.8 | %) | (824.0 | ) | (566.3 | ) | (31.3 | %) | ||||||||||||||
Net cash from operating activities
|
448.8 | 343.1 | (23.6 | %) | 994.0 | 801.8 | (19.3 | %) |
Quarter
|
Year
|
|||||||||||||||||||||||
Turkcell Superonline (million TRY)
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
EBITDA
|
64.1 | 86.0 | 34.2 | % | 237.8 | 327.1 | 37.6 | % | ||||||||||||||||
Income tax expense
|
35.3 | (8.6 | ) | (124.4 | %) | 38.4 | (19.1 | ) | (149.7 | %) | ||||||||||||||
Other operating income / (expense)
|
2.7 | 0.9 | (66.7 | %) | 0.6 | 3.1 | 416.7 | % | ||||||||||||||||
Financial income / (expense)
|
(18.4 | ) | (37.7 | ) | 104.9 | % | (63.7 | ) | (57.8 | ) | (9.3 | %) | ||||||||||||
Net increase / (decrease) in assets and liabilities
|
15.2 | 82.7 | 444.1 | % | (106.0 | ) | 48.0 | (145.3 | %) | |||||||||||||||
Net cash from operating activities
|
98.9 | 123.3 | 24.7 | % | 107.1 | 301.3 | 181.3 | % |
Quarter
|
Year
|
|||||||||||||||||||||||
Euroasia (million US$)
|
Q413 | Q414 | y/y% |
FY13
|
FY14
|
y/y% | ||||||||||||||||||
EBITDA
|
35.2 | 22.2 | (36.9 | %) | 137.1 | 106.3 | (22.5 | %) | ||||||||||||||||
Other operating income / (expense)
|
(0.2 | ) | 0.5 | (350.0 | %) | 1.1 | 1.0 | (9.1 | %) | |||||||||||||||
Financial income / (expense)
|
(9.0 | ) | (13.8 | ) | 53.3 | % | (50.9 | ) | (56.1 | ) | 10.2 | % | ||||||||||||
Net increase / (decrease) in assets and liabilities
|
(27.4 | ) | 15.5 | (156.6 | %) | (10.9 | ) | 17.4 | (259.6 | %) | ||||||||||||||
Net cash from operating activities
|
(1.4 | ) | 24.4 |
n.m.
|
76.4 | 68.6 | (10.2 | %) |
Fourth Quarter and Full Year 2014 Results
|
Investor Relations
Tel: + 90 212 313 1888
investor.relations@turkcell.com.tr
|
Corporate Communications:
Tel: + 90 212 313 2321
Turkcell-Kurumsal-Iletisim@turkcell.com.tr
|
TURKCELL ILETISIM HIZMETLERI A.S.
TURKISH ACCOUNTING STANDARDS SELECTED FINANCIALS (TRY Million)
|
||||||||||||||||||||
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
12 Months Ended
|
12 Months Ended
|
||||||||||||||||
December 31,
|
September 30,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
2013
|
2014
|
2014
|
2013
|
2014
|
||||||||||||||||
Consolidated Statement of Operations Data
|
||||||||||||||||||||
Revenues
|
||||||||||||||||||||
Communication fees
|
2,545.3 | 2,757.5 | 2,631.9 | 10,242.8 | 10,437.2 | |||||||||||||||
Revenues from betting business
|
73.1 | 69.1 | 85.5 | 230.4 | 297.9 | |||||||||||||||
Monthly fixed fees
|
18.2 | 10.0 | 10.4 | 75.9 | 51.5 | |||||||||||||||
Simcard sales
|
7.2 | 11.9 | 6.3 | 29.8 | 31.7 | |||||||||||||||
Call center revenues and other revenues
|
239.8 | 313.7 | 369.1 | 829.0 | 1,225.3 | |||||||||||||||
Total revenues
|
2,883.6 | 3,162.2 | 3,103.2 | 11,407.9 | 12,043.6 | |||||||||||||||
Direct cost of revenues
|
-1,848.9 | -1,879.0 | -1,972.2 | -7,058.9 | -7,380.8 | |||||||||||||||
Gross profit
|
1,034.7 | 1,283.2 | 1,131.0 | 4,349.0 | 4,662.8 | |||||||||||||||
Administrative expenses
|
-152.0 | -138.0 | -146.8 | -550.3 | -562.7 | |||||||||||||||
Selling & marketing expenses
|
-510.4 | -496.5 | -517.8 | -1,843.6 | -1,974.6 | |||||||||||||||
Other Operating Income / (Expense)
|
35.3 | 424.0 | 269.4 | 907.9 | 1,053.6 | |||||||||||||||
Operating profit before financing and investing costs
|
407.6 | 1,072.7 | 735.8 | 2,863.0 | 3,179.1 | |||||||||||||||
Income from investing activities
|
8.9 | 1.7 | 5.4 | 30.2 | 20.0 | |||||||||||||||
Expense from investing activities
|
-15.3 | -10.2 | 9.3 | -58.1 | -16.8 | |||||||||||||||
Share of profit of equity accounted investees
|
75.8 | 66.8 | -6.9 | 297.3 | 207.3 | |||||||||||||||
Income before financing costs
|
477.0 | 1,131.0 | 743.6 | 3,132.4 | 3,389.6 | |||||||||||||||
Finance expense
|
85.1 | -255.6 | -459.8 | -383.2 | -1,424.9 | |||||||||||||||
Monetary gain/(loss)
|
72.5 | 48.3 | 32.3 | 176.9 | 205.1 | |||||||||||||||
Income before tax and non-controlling interest
|
634.6 | 923.7 | 316.1 | 2,926.1 | 2,169.8 | |||||||||||||||
Income tax expense
|
-120.0 | -217.0 | -187.1 | -592.4 | -731.1 | |||||||||||||||
Income before non-controlling interest
|
514.6 | 706.7 | 129.0 | 2,333.7 | 1,438.7 | |||||||||||||||
Non-controlling interest
|
-7.9 | 49.0 | 128.9 | -3.4 | 428.2 | |||||||||||||||
Net income
|
506.7 | 755.7 | 257.9 | 2,330.3 | 1,866.9 | |||||||||||||||
Net income per share
|
0.23 | 0.34 | 0.12 | 1.06 | 0.85 | |||||||||||||||
Other Financial Data
|
||||||||||||||||||||
Gross margin
|
35.9 | % | 40.6 | % | 36.4 | % | 38.1 | % | 38.7 | % | ||||||||||
EBITDA(*)
|
851.5 | 1,050.4 | 917.1 | 3,544.5 | 3,761.8 | |||||||||||||||
Capital expenditures
|
818.5 | 555.1 | 935.3 | 1,822.3 | 2,144.8 | |||||||||||||||
Consolidated Balance Sheet Data (at period end)
|
||||||||||||||||||||
Cash and cash equivalents
|
8,128.9 | 8,692.0 | 9,031.9 | 8,128.9 | 9,031.9 | |||||||||||||||
Total assets
|
21,255.6 | 22,673.4 | 23,668.3 | 21,255.6 | 23,668.3 | |||||||||||||||
Long term debt
|
1,528.5 | 1,101.3 | 1,247.9 | 1,528.5 | 1,247.9 | |||||||||||||||
Total debt
|
3,332.5 | 3,545.0 | 3,697.7 | 3,332.5 | 3,697.7 | |||||||||||||||
Total liabilities
|
6,544.8 | 6,472.5 | 6,979.5 | 6,544.8 | 6,979.5 | |||||||||||||||
Total shareholders’ equity / Net Assets
|
14,710.8 | 16,200.9 | 16,688.8 | 14,710.8 | 16,688.8 | |||||||||||||||
TURKCELL ILETISIM HIZMETLERI A.S.
IFRS SELECTED FINANCIALS (TRY Million)
|
||||||||||||||||||||
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
12 Months Ended
|
12 Months Ended
|
||||||||||||||||
December 31,
|
September 30,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
2013
|
2014
|
2014
|
2013
|
2014
|
||||||||||||||||
Consolidated Statement of Operations Data
|
||||||||||||||||||||
Revenues
|
||||||||||||||||||||
Communication fees
|
2,545.3 | 2,757.5 | 2,631.9 | 10,242.8 | 10,437.2 | |||||||||||||||
Revenues from betting business
|
73.1 | 69.1 | 85.5 | 230.4 | 297.9 | |||||||||||||||
Monthly fixed fees
|
18.2 | 10.0 | 10.4 | 75.9 | 51.5 | |||||||||||||||
Simcard sales
|
7.2 | 11.9 | 6.3 | 29.8 | 31.7 | |||||||||||||||
Call center revenues and other revenues
|
239.8 | 313.7 | 369.1 | 829.0 | 1,225.3 | |||||||||||||||
Total revenues
|
2,883.6 | 3,162.2 | 3,103.2 | 11,407.9 | 12,043.6 | |||||||||||||||
Direct cost of revenues
|
-1,851.3 | -1,880.2 | -1,972.2 | -7,063.9 | -7,383.9 | |||||||||||||||
Gross profit
|
1,032.3 | 1,282.0 | 1,131.0 | 4,344.0 | 4,659.7 | |||||||||||||||
Administrative expenses
|
-152.0 | -138.0 | -146.8 | -550.3 | -562.7 | |||||||||||||||
Selling & marketing expenses
|
-510.4 | -496.5 | -517.8 | -1,843.6 | -1,974.6 | |||||||||||||||
Other Operating Income / (Expense)
|
-35.6 | 17.8 | 1.4 | -58.9 | -76.3 | |||||||||||||||
Operating profit before financing costs
|
334.3 | 665.3 | 467.8 | 1,891.2 | 2,046.1 | |||||||||||||||
Finance costs
|
-89.7 | -83.7 | -400.1 | -204.6 | -1,247.0 | |||||||||||||||
Finance income
|
239.4 | 225.7 | 223.2 | 759.9 | 955.4 | |||||||||||||||
Monetary gain/(loss)
|
72.5 | 48.3 | 32.3 | 176.9 | 205.1 | |||||||||||||||
Share of profit of equity accounted investees
|
75.8 | 66.8 | -6.9 | 297.3 | 207.3 | |||||||||||||||
Income before taxes and minority interest
|
632.3 | 922.4 | 316.3 | 2,920.7 | 2,166.9 | |||||||||||||||
Income tax expense
|
-119.5 | -216.4 | -187.3 | -591.4 | -730.4 | |||||||||||||||
Income before minority interest
|
512.8 | 706.0 | 129.0 | 2,329.3 | 1,436.5 | |||||||||||||||
Non-controlling interests
|
-7.9 | 49.0 | 128.9 | -3.4 | 428.2 | |||||||||||||||
Net income
|
504.9 | 755.0 | 257.9 | 2,325.9 | 1,864.7 | |||||||||||||||
Net income per share
|
0.23 | 0.34 | 0.12 | 1.06 | 0.85 | |||||||||||||||
Other Financial Data
|
||||||||||||||||||||
Gross margin
|
35.8 | % | 40.5 | % | 36.4 | % | 38.1 | % | 38.7 | % | ||||||||||
EBITDA(*)
|
851.5 | 1,050.4 | 917.1 | 3,544.5 | 3,761.8 | |||||||||||||||
Capital expenditures
|
818.5 | 555.1 | 935.3 | 1,822.3 | 2,144.8 | |||||||||||||||
Consolidated Balance Sheet Data (at period end)
|
||||||||||||||||||||
Cash and cash equivalents
|
8,128.9 | 8,692.0 | 9,031.9 | 8,128.9 | 9,031.9 | |||||||||||||||
Total assets
|
21,284.6 | 22,699.3 | 23,694.2 | 21,284.6 | 23,694.2 | |||||||||||||||
Long term debt
|
1,528.5 | 1,101.3 | 1,247.9 | 1,528.5 | 1,247.9 | |||||||||||||||
Total debt
|
3,332.5 | 3,545.0 | 3,697.7 | 3,332.5 | 3,697.7 | |||||||||||||||
Total liabilities
|
6,549.5 | 6,476.3 | 6,983.6 | 6,549.5 | 6,983.6 | |||||||||||||||
Total shareholders’ equity / Net Assets
|
14,735.1 | 16,223.0 | 16,710.6 | 14,735.1 | 16,710.6 |
TURKCELL ILETISIM HIZMETLERI A.S.
IFRS SELECTED FINANCIALS (US$ MILLION)
|
||||||||||||||||||||
Quarter Ended
|
Quarter Ended
|
Quarter Ended
|
12 Months Ended
|
12 Months Ended
|
||||||||||||||||
December 31,
|
September 30,
|
December 31,
|
December 31,
|
December 31,
|
||||||||||||||||
2013
|
2014
|
2014
|
2013
|
2014
|
||||||||||||||||
Consolidated Statement of Operations Data
|
||||||||||||||||||||
Revenues
|
||||||||||||||||||||
Communication fees
|
1,252.0 | 1,280.6 | 1,172.7 | 5,369.0 | 4,779.3 | |||||||||||||||
Revenues from betting business
|
36.0 | 32.1 | 38.2 | 120.4 | 136.1 | |||||||||||||||
Monthly fixed fees
|
9.0 | 4.6 | 4.7 | 40.0 | 23.6 | |||||||||||||||
Simcard sales
|
3.6 | 5.6 | 2.8 | 15.6 | 14.6 | |||||||||||||||
Call center revenues and other revenues
|
117.0 | 144.7 | 164.2 | 430.4 | 559.3 | |||||||||||||||
Total revenues
|
1,417.6 | 1,467.6 | 1,382.6 | 5,975.4 | 5,512.9 | |||||||||||||||
Direct cost of revenues
|
-905.6 | -870.4 | -877.6 | -3,693.3 | -3,375.5 | |||||||||||||||
Gross profit
|
512.0 | 597.2 | 505.0 | 2,282.1 | 2,137.4 | |||||||||||||||
Administrative expenses
|
-74.3 | -63.6 | -65.2 | -286.8 | -256.8 | |||||||||||||||
Selling & marketing expenses
|
-250.7 | -230.3 | -230.7 | -964.1 | -903.1 | |||||||||||||||
Other Operating Income / (Expense)
|
-16.9 | 8.7 | 0.6 | -29.2 | -35.5 | |||||||||||||||
Operating profit before financing costs
|
170.1 | 312.0 | 209.7 | 1,002.0 | 942.0 | |||||||||||||||
Finance expense
|
-39.1 | -37.6 | -175.4 | -95.5 | -559.3 | |||||||||||||||
Finance income
|
117.3 | 105.8 | 98.9 | 395.4 | 437.5 | |||||||||||||||
Monetary gain/(loss)
|
31.6 | 17.1 | 12.6 | 82.9 | 88.4 | |||||||||||||||
Share of profit of equity accounted investees
|
37.4 | 31.4 | -2.7 | 155.4 | 96.6 | |||||||||||||||
Income before taxes and minority interest
|
317.3 | 428.7 | 143.1 | 1,540.2 | 1,005.2 | |||||||||||||||
Income tax expense
|
-59.4 | -100.5 | -83.5 | -310.7 | -334.6 | |||||||||||||||
Income before minority interest
|
257.9 | 328.2 | 59.6 | 1,229.5 | 670.6 | |||||||||||||||
Minority interest
|
-3.9 | 23.8 | 57.9 | -1.3 | 194.3 | |||||||||||||||
Net income
|
254.0 | 352.0 | 117.5 | 1,228.2 | 864.9 | |||||||||||||||
Net income per share
|
0.12 | 0.16 | 0.05 | 0.56 | 0.39 | |||||||||||||||
Other Financial Data
|
||||||||||||||||||||
Gross margin
|
36.1 | % | 40.7 | % | 36.5 | % | 38.2 | % | 38.8 | % | ||||||||||
EBITDA(*)
|
420.4 | 489.1 | 409.1 | 1,858.0 | 1,725.2 | |||||||||||||||
Capital expenditures
|
360.3 | 222.5 | 394.2 | 853.8 | 924.9 | |||||||||||||||
Consolidated Balance Sheet Data (at period end)
|
||||||||||||||||||||
Cash and cash equivalents
|
3,808.7 | 3,814.1 | 3,894.9 | 3,808.7 | 3,894.9 | |||||||||||||||
Total assets
|
9,972.6 | 9,960.6 | 10,217.9 | 9,972.6 | 10,217.9 | |||||||||||||||
Long term debt
|
716.2 | 483.3 | 538.1 | 716.2 | 538.1 | |||||||||||||||
Total debt
|
1,561.4 | 1,555.6 | 1,594.6 | 1,561.4 | 1,594.6 | |||||||||||||||
Total liabilities
|
3,068.7 | 2,841.8 | 3,011.6 | 3,068.7 | 3,011.6 | |||||||||||||||
Total equity
|
6,903.9 | 7,118.8 | 7,206.3 | 6,903.9 | 7,206.3 | |||||||||||||||
* Please refer to the notes on reconciliation of Non-GAAP Financial measures on page 16
|
||||||||||||||||||||
** For further details, please refer to our consolidated financial statements and notes as at 31 December 2014 on our web site.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
|
As at 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
Note
|
2014
|
2013
|
||||||||||
Assets
|
||||||||||||
Property, plant and equipment
|
13 | 2,541,547 | 2,747,813 | |||||||||
Intangible assets
|
14 | 1,055,411 | 1,106,871 | |||||||||
GSM and other telecommunication operating licenses
|
432,140 | 522,065 | ||||||||||
Computer software
|
576,482 | 544,140 | ||||||||||
Other intangible assets
|
46,789 | 40,666 | ||||||||||
Investment properties
|
15 | 5,778 | 7,639 | |||||||||
Investments in equity accounted investees
|
16 | 287,869 | 250,959 | |||||||||
Other investments
|
17 | - | 3,851 | |||||||||
Other non-current assets
|
18 | 226,651 | 117,968 | |||||||||
Trade receivables
|
20 | 336,334 | 247,823 | |||||||||
Deferred tax assets
|
19 | 25,475 | 34,333 | |||||||||
Total non-current assets
|
4,479,065 | 4,517,257 | ||||||||||
Inventories
|
30,757 | 32,845 | ||||||||||
Other investments
|
17 | 8,344 | 27,028 | |||||||||
Due from related parties
|
35 | 5,579 | 10,012 | |||||||||
Trade receivables and accrued income
|
20 | 1,510,421 | 1,294,636 | |||||||||
Other current assets
|
21 | 288,803 | 282,152 | |||||||||
Cash and cash equivalents
|
22 | 3,894,898 | 3,808,708 | |||||||||
Total current assets
|
5,738,802 | 5,455,381 | ||||||||||
Total assets
|
10,217,867 | 9,972,638 | ||||||||||
Equity
|
||||||||||||
Share capital
|
23 | 1,636,204 | 1,636,204 | |||||||||
Share premium
|
23 | 434 | 434 | |||||||||
Capital contributions
|
23 | 22,772 | 22,772 | |||||||||
Reserves
|
23 | (3,586,074 | ) | (3,105,434 | ) | |||||||
Retained earnings
|
23 | 9,298,013 | 8,435,045 | |||||||||
Total equity attributable to equity holders of Turkcell Iletisim Hizmetleri AS
|
7,371,349 | 6,989,021 | ||||||||||
Non-controlling interests
|
(165,068 | ) | (85,055 | ) | ||||||||
Total equity
|
7,206,281 | 6,903,966 | ||||||||||
Liabilities
|
||||||||||||
Loans and borrowings
|
26 | 538,128 | 716,150 | |||||||||
Employee benefits
|
27 | 41,519 | 38,709 | |||||||||
Provisions
|
29 | 120,051 | 135,524 | |||||||||
Other non-current liabilities
|
25 | 133,490 | 127,669 | |||||||||
Deferred tax liabilities
|
19 | 26,009 | 30,751 | |||||||||
Total non-current liabilities
|
859,197 | 1,048,803 | ||||||||||
Bank overdraft
|
22 | - | 237 | |||||||||
Loans and borrowings
|
26 | 1,056,808 | 846,245 | |||||||||
Income taxes payable
|
12 | 66,749 | 65,074 | |||||||||
Trade and other payables
|
30 | 891,424 | 891,515 | |||||||||
Due to related parties
|
35 | 10,624 | 42,278 | |||||||||
Deferred income
|
28 | 70,906 | 92,221 | |||||||||
Provisions
|
29 | 55,878 | 82,299 | |||||||||
Total current liabilities
|
2,152,389 | 2,019,869 | ||||||||||
Total liabilities
|
3,011,586 | 3,068,672 | ||||||||||
Total equity and liabilities
|
10,217,867 | 9,972,638 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
CONSOLIDATED STATEMENT OF PROFIT OR LOSS
|
For the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
Note
|
2014
|
2013
|
2012
|
|||||||||||||
Revenue
|
8 | 5,512,854 | 5,975,407 | 5,865,787 | ||||||||||||
Direct costs of revenue
|
(3,375,484 | ) | (3,693,270 | ) | (3,622,309 | ) | ||||||||||
Gross profit
|
2,137,370 | 2,282,137 | 2,243,478 | |||||||||||||
Other income
|
9 | 27,121 | 18,243 | 18,094 | ||||||||||||
Selling and marketing expenses
|
(903,085 | ) | (964,120 | ) | (953,187 | ) | ||||||||||
Administrative expenses
|
(256,771 | ) | (286,750 | ) | (270,477 | ) | ||||||||||
Other expenses
|
9 | (62,654 | ) | (47,464 | ) | (76,924 | ) | |||||||||
Results from operating activities
|
941,981 | 1,002,046 | 960,984 | |||||||||||||
Finance income
|
11 | 437,519 | 395,396 | 386,088 | ||||||||||||
Finance costs
|
11 | (559,366 | ) | (95,515 | ) | (125,510 | ) | |||||||||
Net finance (cost) / income
|
(121,847 | ) | 299,881 | 260,578 | ||||||||||||
Monetary gain
|
88,433 | 82,871 | 95,325 | |||||||||||||
Share of profit of equity accounted investees
|
16 | 96,596 | 155,362 | 121,733 | ||||||||||||
Profit before income tax
|
1,005,163 | 1,540,160 | 1,438,620 | |||||||||||||
Income tax expense
|
12 | (334,578 | ) | (310,696 | ) | (291,491 | ) | |||||||||
Profit for the year
|
670,585 | 1,229,464 | 1,147,129 | |||||||||||||
Profit / (loss) attributable to:
|
||||||||||||||||
Owners of Turkcell Iletisim Hizmetleri AS
|
864,924 | 1,228,188 | 1,158,835 | |||||||||||||
Non-controlling interests
|
(194,339 | ) | 1,276 | (11,706 | ) | |||||||||||
Profit for the year
|
670,585 | 1,229,464 | 1,147,129 | |||||||||||||
Basic and diluted earnings per share
|
24 | 0.39 | 0.56 | 0.53 | ||||||||||||
(in full USD)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND
OTHER COMPREHENSIVE INCOME |
For the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2014
|
2013
|
2012
|
||||||||||
Profit for the year
|
670,585 | 1,229,464 | 1,147,129 | |||||||||
|
||||||||||||
Other comprehensive income / (expense):
|
||||||||||||
Items that will not be reclassified to profit or loss:
|
||||||||||||
Foreign currency translation differences
|
(601,204 | ) | (1,318,211 | ) | 348,980 | |||||||
Actuarial (loss) / gain arising from employee benefits
|
(360 | ) | 2,478 | (4,911 | ) | |||||||
Tax effect of actuarial gain / (loss) from employee benefits
|
88 | (482 | ) | 960 | ||||||||
(601,476 | ) | (1,316,215 | ) | 345,029 | ||||||||
Items that will or may be reclassified subsequently to profit or loss:
|
||||||||||||
Change in cash flow hedge reserve
|
538 | 471 | (860 | ) | ||||||||
Foreign currency translation differences
|
206,026 | (109,207 | ) | (13,811 | ) | |||||||
Share of foreign currency translation differences of the equity accounted investees
|
(3,997 | ) | 21,626 | (22,461 | ) | |||||||
Tax effect of foreign currency translation differences
|
(937 | ) | 3,170 | 2,145 | ||||||||
201,630 | (83,940 | ) | (34,987 | ) | ||||||||
Other comprehensive (expense) / income for the year, net of income tax
|
(399,846 | ) | (1,400,155 | ) | 310,042 | |||||||
Total comprehensive income / (expense) for the year
|
270,739 | (170,691 | ) | 1,457,171 | ||||||||
Total comprehensive income / (expense) attributable to:
|
||||||||||||
Owners of Turkcell Iletisim Hizmetleri AS
|
348,632 | (164,811 | ) | 1,467,154 | ||||||||
Non-controlling interests
|
(77,893 | ) | (5,880 | ) | (9,983 | ) | ||||||
Total comprehensive income / (expense) for the year
|
270,739 | (170,691 | ) | 1,457,171 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
|
For the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
Attributable to equity holders of the Company | ||||||||||||||||||||||||||||||||||||||||||||
Share Capital
|
Capital Contribution
|
Share Premium
|
Legal Reserves
|
Cash Flow Hedge Reserves
|
Reserve for Non-Controlling Interest Put Option
|
Translation Reserve
|
Retained
Earnings
|
Total
|
Non-Controlling Interest
|
Total
Equity
|
||||||||||||||||||||||||||||||||||
Balance at 1 January 2012
|
1,636,204 | 22,772 | 434 | 533,939 | (459 | ) | (242,217 | ) | (2,212,237 | ) | 6,053,702 | 5,792,138 | (60,533 | ) | 5,731,605 | |||||||||||||||||||||||||||||
Total comprehensive income
|
||||||||||||||||||||||||||||||||||||||||||||
Profit / (loss) for the year
|
- | - | - | - | - | - | - | 1,158,835 | 1,158,835 | (11,706 | ) | 1,147,129 | ||||||||||||||||||||||||||||||||
Other comprehensive income/(expense)
|
||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation differences, net of tax
|
- | - | - | - | - | 3,951 | 309,179 | - | 313,130 | 1,723 | 314,853 | |||||||||||||||||||||||||||||||||
Actuarial loss arising from employee benefits
|
- | - | - | - | - | - | - | (3,951 | ) | (3,951 | ) | - | (3,951 | ) | ||||||||||||||||||||||||||||||
Change in cash flow hedge reserve
|
- | - | - | - | (860 | ) | - | - | - | (860 | ) | - | (860 | ) | ||||||||||||||||||||||||||||||
Total other comprehensive income/(expense)
|
- | - | - | - | (860 | ) | 3,951 | 309,179 | (3,951 | ) | 308,319 | 1,723 | 310,042 | |||||||||||||||||||||||||||||||
Total comprehensive income/(expense) , net of tax
|
- | - | - | - | (860 | ) | 3,951 | 309,179 | 1,154,884 | 1,467,154 | (9,983 | ) | 1,457,171 | |||||||||||||||||||||||||||||||
Transfers to legal reserves
|
- | - | - | 1,023 | - | - | - | (1,023 | ) | - | - | - | ||||||||||||||||||||||||||||||||
Dividend paid (Note 23)
|
- | - | - | - | - | - | - | - | - | (8,485 | ) | (8,485 | ) | |||||||||||||||||||||||||||||||
Change in non-controlling interest
|
- | - | - | - | - | - | - | - | - | 282 | 282 | |||||||||||||||||||||||||||||||||
Change in reserve for non-controlling interest put option
|
- | - | - | - | - | (20,429 | ) | - | - | (20,429 | ) | - | (20,429 | ) | ||||||||||||||||||||||||||||||
Balance at 31 December 2012
|
1,636,204 | 22,772 | 434 | 534,962 | (1,319 | ) | (258,695 | ) | (1,903,058 | ) | 7,207,563 | 7,238,863 | (78,719 | ) | 7,160,144 | |||||||||||||||||||||||||||||
Balance at 1 January 2013
|
1,636,204 | 22,772 | 434 | 534,962 | (1,319 | ) | (258,695 | ) | (1,903,058 | ) | 7,207,563 | 7,238,863 | (78,719 | ) | 7,160,144 | |||||||||||||||||||||||||||||
Total comprehensive income
|
||||||||||||||||||||||||||||||||||||||||||||
Profit / (loss) for the year
|
- | - | - | - | - | - | - | 1,228,188 | 1,228,188 | 1,276 | 1,229,464 | |||||||||||||||||||||||||||||||||
Other comprehensive income/(expense)
|
||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation differences, net of tax
|
- | - | - | - | - | (13,337 | ) | (1,382,129 | ) | - | (1,395,466 | ) | (7,156 | ) | (1,402,622 | ) | ||||||||||||||||||||||||||||
Actuarial gain arising from employee benefits
|
- | - | - | - | - | - | - | 1,996 | 1,996 | - | 1,996 | |||||||||||||||||||||||||||||||||
Change in cash flow hedge reserve
|
- | - | - | - | 471 | - | - | - | 471 | - | 471 | |||||||||||||||||||||||||||||||||
Total other comprehensive income/(expense), net of tax
|
- | - | - | - | 471 | (13,337 | ) | (1,382,129 | ) | 1,996 | (1,392,999 | ) | (7,156 | ) | (1,400,155 | ) | ||||||||||||||||||||||||||||
Total comprehensive income/(expense)
|
- | - | - | - | 471 | (13,337 | ) | (1,382,129 | ) | 1,230,184 | (164,811 | ) | (5,880 | ) | (170,691 | ) | ||||||||||||||||||||||||||||
Transfers to legal reserves
|
- | - | - | 2,702 | - | - | - | (2,702 | ) | - | - | - | ||||||||||||||||||||||||||||||||
Dividend paid (Note 23)
|
- | - | - | - | - | - | - | - | - | (490 | ) | (490 | ) | |||||||||||||||||||||||||||||||
Change in non-controlling interest
|
- | - | - | - | - | - | - | - | - | 34 | 34 | |||||||||||||||||||||||||||||||||
Change in reserve for non-controlling interest put option
|
- | - | - | - | - | (85,031 | ) | - | - | (85,031 | ) | - | (85,031 | ) | ||||||||||||||||||||||||||||||
Balance at 31 December 2013
|
1,636,204 | 22,772 | 434 | 537,664 | (848 | ) | (357,063 | ) | (3,285,187 | ) | 8,435,045 | 6,989,021 | (85,055 | ) | 6,903,966 | |||||||||||||||||||||||||||||
Balance at 1 January 2014
|
1,636,204 | 22,772 | 434 | 537,664 | (848 | ) | (357,063 | ) | (3,285,187 | ) | 8,435,045 | 6,989,021 | (85,055 | ) | 6,903,966 | |||||||||||||||||||||||||||||
Total comprehensive income
|
||||||||||||||||||||||||||||||||||||||||||||
Profit / (loss) for the year
|
- | - | - | - | - | - | - | 864,924 | 864,924 | (194,339 | ) | 670,585 | ||||||||||||||||||||||||||||||||
Other comprehensive income/(expense)
|
||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation differences, net of tax
|
- | - | - | - | - | (5,382 | ) | (511,176 | ) | - | (516,558 | ) | 116,446 | (400,112 | ) | |||||||||||||||||||||||||||||
Actuarial loss arising from employee benefits
|
- | - | - | - | - | - | - | (272 | ) | (272 | ) | - | (272 | ) | ||||||||||||||||||||||||||||||
Change in cash flow hedge reserve
|
- | - | - | - | 538 | - | - | - | 538 | - | 538 | |||||||||||||||||||||||||||||||||
Total other comprehensive income/(expense), net of tax
|
- | - | - | - | 538 | (5,382 | ) | (511,176 | ) | (272 | ) | (516,292 | ) | 116,446 | (399,846 | ) | ||||||||||||||||||||||||||||
Total comprehensive income/(expense)
|
- | - | - | - | 538 | (5,382 | ) | (511,176 | ) | 864,652 | 348,632 | (77,893 | ) | 270,739 | ||||||||||||||||||||||||||||||
Dividend paid (Note 23)
|
- | - | - | - | - | - | - | - | - | (3,772 | ) | (3,772 | ) | |||||||||||||||||||||||||||||||
Change in non-controlling interest
|
- | - | - | - | - | - | - | - | - | (32 | ) | (32 | ) | |||||||||||||||||||||||||||||||
Change in fair value of minority put option
|
- | - | - | - | - | 35,380 | - | - | 35,380 | - | 35,380 | |||||||||||||||||||||||||||||||||
Acquisition of non-controlling interest
|
- | - | - | - | - | - | - | (1,684 | ) | (1,684 | ) | 1,684 | - | |||||||||||||||||||||||||||||||
Balance at 31 December 2014
|
1,636,204 | 22,772 | 434 | 537,664 | (310 | ) | (327,065 | ) | (3,796,363 | ) | 9,298,013 | 7,371,349 | (165,068 | ) | 7,206,281 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
CONSOLIDATED STATEMENT OF CASH FLOWS
|
For the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
Note
|
2014
|
2013
|
2012
|
|||||||||||||
Cash flows from operating activities
|
||||||||||||||||
Profit for the year
|
670,585 | 1,229,464 | 1,147,129 | |||||||||||||
Adjustments for:
|
||||||||||||||||
Depreciation and impairment of fixed assets
|
13 | 527,736 | 589,786 | 562,788 | ||||||||||||
Amortization of intangible assets
|
14 | 219,930 | 236,994 | 225,844 | ||||||||||||
Net finance (income)
|
11 | (416,026 | ) | (369,481 | ) | (317,295 | ) | |||||||||
Income tax expense
|
12 | 334,578 | 310,696 | 291,491 | ||||||||||||
Share of profit of equity accounted investees
|
16, 35 | (105,431 | ) | (155,362 | ) | (134,995 | ) | |||||||||
(Gain)/loss on sale of property, plant and equipment
|
(4,803 | ) | (7,566 | ) | (2,599 | ) | ||||||||||
Unrealized foreign exchange and monetary gain/loss on operating assets
|
274,068 | (248,140 | ) | (40,855 | ) | |||||||||||
Allowance for trade receivables and due from related parties
|
30 | 71,029 | 79,465 | 62,431 | ||||||||||||
Negative goodwill
|
(952 | ) | (96 | ) | ||||||||||||
Deferred income
|
27 | (11,895 | ) | 21,073 | (34,269 | ) | ||||||||||
Provision for equity accounted investees
|
9 | - | - | 19,299 | ||||||||||||
Reversal of provision for equity accounted investees
|
(8,835 | ) | - | - | ||||||||||||
Loss on sale of A-tel
|
416 | - | - | |||||||||||||
Impairment losses on equity accounted investees and other non-current investments
|
- | 19,242 | 40,250 | |||||||||||||
1,550,400 | 1,706,075 | 1,819,219 | ||||||||||||||
Change in trade receivables
|
20 | (473,202 | ) | (384,407 | ) | (487,538 | ) | |||||||||
Change in due from related parties
|
35 | 3,905 | (3,442 | ) | 37,583 | |||||||||||
Change in inventories
|
(1,205 | ) | 7,999 | (21,279 | ) | |||||||||||
Change in other current assets
|
21 | (33,357 | ) | (47,547 | ) | (45,798 | ) | |||||||||
Change in other non-current assets
|
18 | (13,709 | ) | (13,265 | ) | (21,278 | ) | |||||||||
Change in due to related parties
|
35 | 3,619 | (4,333 | ) | 1,669 | |||||||||||
Change in trade and other payables
|
84,892 | 45,762 | (4,859 | ) | ||||||||||||
Change in other non-current liabilities
|
25 | 13,464 | 19,870 | (11,840 | ) | |||||||||||
Change in employee benefits
|
27 | 5,531 | 6,562 | 6,596 | ||||||||||||
Change in provisions
|
29 | (21,999 | ) | 16,300 | 40,007 | |||||||||||
1,118,339 | 1,349,574 | 1,312,482 | ||||||||||||||
Interest paid
|
(42,961 | ) | (59,122 | ) | (56,343 | ) | ||||||||||
Income tax paid
|
(317,659 | ) | (337,805 | ) | (307,262 | ) | ||||||||||
Dividends received
|
44,103 | 41,347 | 239,377 | |||||||||||||
Net cash generated by operating activities
|
801,822 | 993,994 | 1,188,254 | |||||||||||||
Cash flows from investing activities
|
||||||||||||||||
Acquisition of property, plant and equipment
|
(669,970 | ) | (631,398 | ) | (758,898 | ) | ||||||||||
Acquisition of intangible assets
|
14 | (248,344 | ) | (215,536 | ) | (208,040 | ) | |||||||||
Proceeds from sale of property, plant and equipment
|
12,570 | 11,027 | 9,679 | |||||||||||||
Proceeds from currency option contracts
|
11 | 1,274 | 484 | 2,250 | ||||||||||||
Payment of currency option contracts premium
|
11 | (15 | ) | (106 | ) | (280 | ) | |||||||||
Change in financial assets
|
20,950 | (9,739 | ) | 869,697 | ||||||||||||
Acquisition of subsidiary net off cash acquired
|
7 | (12,747 | ) | (746 | ) | - | ||||||||||
Proceeds from sale of A-tel
|
275 | - | - | |||||||||||||
Advanced paid for a acquisition of property, plant and equipment
|
(110,865 | ) | - | - | ||||||||||||
Interest received
|
433,763 | 376,355 | 390,155 | |||||||||||||
Net cash provided/(used in) investing activities
|
(573,109 | ) | (469,659 | ) | 304,563 | |||||||||||
Cash flows from financing activities
|
||||||||||||||||
Proceeds from issuance of loans and borrowings
|
2,100,747 | 898,106 | 670,549 | |||||||||||||
Repayment of borrowings
|
(2,057,451 | ) | (1,019,250 | ) | (833,552 | ) | ||||||||||
Change in non-controlling interest
|
(32 | ) | 34 | 282 | ||||||||||||
Dividends paid
|
(3,772 | ) | (490 | ) | (8,485 | ) | ||||||||||
Net cash generated (used in) by financing activities
|
39,492 | (121,600 | ) | (171,206 | ) | |||||||||||
Net increase/ (decrease) in cash and cash equivalents
|
268,205 | 402,735 | 1,321,611 | |||||||||||||
Cash and cash equivalents at 1 January
|
3,808,471 | 3,926,215 | 2,507,445 | |||||||||||||
Effects of foreign exchange rate fluctuations on cash and cash equivalents
|
(181,778 | ) | (520,479 | ) | 97,159 | |||||||||||
Cash and cash equivalents at 31 December
|
22 | 3,894,898 | 3,808,471 | 3,926,215 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
Notes to the consolidated financial statements
|
|
Page
|
|
1. Reporting entity
|
7
|
2. Basis of preparation
|
8
|
3. Significant accounting policies
|
17
|
4. Determination of fair values
|
48
|
5. Financial risk management
|
50
|
6. Operating segments
|
53
|
7. Acquisition of subsidiaries
|
58
|
8. Revenue
|
60
|
9. Other income and expenses
|
60
|
10. Personnel expenses
|
61
|
11. Finance income and costs
|
61
|
12. Income tax expense
|
62
|
13. Property, plant and equipment
|
64
|
14. Intangible assets
|
66
|
15. Investment property
|
71
|
16. Investments in equity accounted investees
|
72
|
17. Other investments
|
75
|
18. Other non-current assets
|
75
|
19. Deferred tax assets and liabilities
|
76
|
20. Trade receivables and accrued income
|
79
|
21. Other current assets
|
79
|
22. Cash and cash equivalents
|
80
|
23. Capital and reserves
|
80
|
24. Earnings per share
|
83
|
25. Other non-current liabilities
|
83
|
26. Loans and borrowings
|
84
|
27. Employee benefits
|
87
|
28. Deferred income
|
88
|
29. Provisions
|
89
|
30. Trade and other payables
|
90
|
31. Financial instruments
|
91
|
32. Operating leases
|
99
|
33. Guarantees and purchase obligations
|
100
|
34. Commitments and contingencies
|
101
|
35. Related parties
|
156
|
36. Subsidiaries
|
162
|
37. Subsequent events
|
165
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
1.
|
Reporting entity
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation
|
(a)
|
Statement of compliance
|
(b)
|
Basis of measurement
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(b)
|
Basis of measurement (continued)
|
Dates
|
Index
|
Conversion Factor
|
31 December 2010
|
1.6387
|
3.4406
|
31 December 2011
|
3.4197
|
1.6487
|
31 December 2012
|
4.1645
|
1.3538
|
31 December 2013
|
4.8501
|
1.1625
|
31 December 2014
|
5.6381
|
1.0000
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(b)
|
Basis of measurement (continued)
|
Years
|
2012
|
2013
|
2014
|
Currency change USD (%)
|
3%
|
11%
|
25%
|
Currency change Euro (%)
|
5%
|
15%
|
10%
|
CPI inflation (%)
|
22%
|
16%
|
16%
|
-
|
All statement of financial of position items, except for the ones already presented at the current purchasing power level, are restated by applying a general price index.
|
-
|
Monetary assets and liabilities of the subsidiaries operating in Belarus are not restated because they are already expressed in terms of the current measuring unit at the balance sheet date. Monetary items presents money held and items to be received or paid in money.
|
-
|
Non-monetary assets and liabilities of the subsidiaries operating in Belarus are restated by applying, to the initial acquisition cost and any accumulated depreciation, the change in the general price index from the date of acquisition or initial recording to the balance sheet date. Hence, property, plant and equipment, investments and similar assets are restated from the date of their purchase, not to exceed their market value. Depreciation is similarly restated. The components of shareholders’ equity are restated by applying the applicable general price index from the dates the components were contributed or arose otherwise.
|
-
|
All items in the statement of profit or loss of the subsidiaries operating in Belarus, except non-monetary items in the statement of financial position that have effect over statement of profit or loss, are restated by applying the relevant conversion factors from the dates when the income and expense items were initially recorded in the financial statements.
|
-
|
The gain or loss on the net monetary position is the result of the effect of general inflation and is the difference resulting from the restatement of non-monetary assets, shareholders’ equity and statement of profit or loss items. The gain or loss on the net monetary position is included in net income.
|
-
|
The comparative amounts relating to the subsidiaries operating in Belarus in the consolidated financial statements of 2011, 2012 and 2013 are not restated. The translation effect of Belarusian Ruble (“BYR”) denominated equity accounts determined upon the application of inflation accounting to USD is accounted under translation reserve in the consolidated financial statements as at 31 December 2014.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(c)
|
Functional and presentation currency
|
(d)
|
Use of estimates and judgments
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(d)
|
Use of estimates and judgments (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(d)
|
Use of estimates and judgments (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(d)
|
Use of estimates and judgments (continued)
|
|
·
|
The Group does not take the responsibility for fulfillment of the games.
|
|
·
|
The Group does not collect the proceeds from the final customer and it does not bear the credit risk.
|
|
·
|
The Group earns a pre-determined percentage of the total turnover.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(d)
|
Use of estimates and judgments (continued)
|
|
·
|
the component has standalone value to the customer; and
|
|
·
|
the fair value of the component can be measured reliably.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
2.
|
Basis of preparation (continued)
|
(d)
|
Use of estimates and judgments (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies
|
(a)
|
Basis of consolidation
|
(i)
|
Business combinations
|
|
•
|
deferred tax assets or liabilities, and assets or liabilities related to employee benefit arrangements are recognized and measured in accordance with IAS 12 “Income Taxes” and IAS 19 “Employee Benefits” respectively;
|
|
•
|
liabilities or equity instruments related to share-based payment arrangements of the acquiree or share-based payment arrangements of the Group entered into to replace share-based payment arrangements of the acquiree are measured in accordance with IFRS 2 at the acquisition date; and
|
|
•
|
assets (or disposal groups) that are classified as held for sale in accordance with IFRS 5 “Non-current Assets Held for Sale and Discontinued Operations” are measured in accordance with that Standard.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(a)
|
Basis of consolidation (continued)
|
(i)
|
Business combinations (continued)
|
•
|
has power over the investee;
|
•
|
is exposed, or has rights, to variable returns from its involvement with the investee; and
|
•
|
has the ability to use its power to affect its returns.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(a)
|
Basis of consolidation (continued)
|
(ii)
|
Subsidiaries (continued)
|
•
|
the size of the Company’s holding of voting rights relative to the size and dispersion of holdings of the other vote holders;
|
•
|
potential voting rights held by the Company, other vote holders or other parties;
|
•
|
rights arising from other contractual arrangements; and
|
•
|
any additional facts and circumstances that indicate that the Company has, or does not have, the current ability to direct the relevant activities at the time that decisions need to be made, including voting patterns at previous shareholders’ meetings.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(a)
|
Basis of consolidation (continued)
|
(iii)
|
Changes in the Group’s ownership interests in existing subsidiaries
|
(iv)
|
Acquisition from entities under common control
|
(v)
|
Transactions eliminated on consolidation
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(a)
|
Basis of consolidation (continued)
|
(vi)
|
Non-controlling interests
|
(vii)
|
Investments in associates and joint ventures
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(a)
|
Basis of consolidation (continued)
|
(vii)
|
Investments in associates and joint ventures (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(a)
|
Basis of consolidation (continued)
|
(vii)
|
Investments in associates and joint ventures (continued)
|
(b)
|
Foreign currency
|
(i)
|
Foreign currency transactions
|
(ii)
|
Foreign operations
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(b)
|
Foreign currency (continued)
|
(ii)
|
Foreign operations (continued)
|
(iii)
|
Translation from functional to presentation currency
|
(c)
|
Financial instruments
|
(i)
|
Non-derivative financial instruments
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(c)
|
Financial instruments (continued)
|
(ii)
|
Derecognition of financial assets
|
·
|
Financial assets at fair value through profit or loss
|
|
·
|
it has been acquired principally for the purpose of selling it in the near term; or
|
|
·
|
on initial recognition it is part of a portfolio of identified financial instruments that the Group manages together and has a recent actual pattern of short-term profit-taking; or
|
|
·
|
it is a derivative that is not designated and effective as a hedging instrument.
|
|
·
|
such designation eliminates or significantly reduces a measurement or recognition inconsistency that would otherwise arise; or
|
|
·
|
the financial asset forms part of a group of financial assets or financial liabilities or both, which is managed and its performance is evaluated on a fair value basis, in accordance with the Group’s documented risk management or investment strategy, and information about the grouping is provided internally on that basis; or
|
|
·
|
it forms part of a contract containing one or more embedded derivatives, and IAS 39 permits the entire combined contract to be designated as at fair value through profit or loss.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(c)
|
Financial instruments (continued)
|
(ii)
|
Derecognition of financial assets (continued)
|
|
·
|
Held-to-maturity financial assets
|
·
|
Estimated exercise price of put options
|
|
·
|
Other
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(c)
|
Financial instruments (continued)
|
(iii)
|
Derivative financial instruments
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(d)
|
Property, plant and equipment
|
(i)
|
Recognition and measurement
|
(ii)
|
Subsequent costs
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(d)
|
Property, plant and equipment
|
(iii)
|
Depreciation
|
Buildings
|
21 – 50 years
|
Mobile network infrastructure
|
4 – 12 years
|
Fixed network infrastructure
|
3 – 25 years
|
Call center equipment
|
4 – 8 years
|
Equipment, fixtures and fittings
|
3 – 10 years
|
Motor vehicles
|
4 – 6 years
|
Central betting terminals
|
5 – 10 years
|
Leasehold improvements
|
3 – 5 years
|
(e)
|
Intangible assets
|
(i)
|
GSM and other telecommunication operating licenses
|
Amortization
|
GSM and other telecommunications licenses
|
3 – 25 years
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(e)
|
Intangible assets (continued)
|
(ii)
|
Computer Software
|
Computer software
|
3 – 8 years
|
(iii)
|
Other intangible assets
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(e)
|
Intangible assets (continued)
|
Transmission lines
|
5 – 10 years
|
Central betting system operating right
|
7 – 10 years
|
Customer base
|
2 – 15 years
|
Brand name
|
9 – 10 years
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(e)
|
Intangible assets (continued)
|
(iv)
|
Internally generated intangible assets – research and development expenditure
|
|
·
|
The technical feasibility of completing the intangible asset so that it will be available for use or sale;
|
|
·
|
The intention to complete the intangible asset and use or sell it;
|
|
·
|
The ability to use or sell the intangible asset;
|
|
·
|
How the intangible asset will generate probable future economic benefits;
|
|
·
|
The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
|
|
·
|
The ability to measure reliably the expenditure attributable to the intangible asset during its development.
|
(v)
|
Derecognition of intangible assets
|
(f)
|
Leased assets
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(g)
|
Inventories
|
(h)
|
Impairment
|
(i)
|
Financial assets
|
(ii)
|
Non-financial assets
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(h)
|
Impairment (continued)
|
(ii)
|
Non-financial assets (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(i)
|
Employee benefits
|
(i)
|
Retirement pay liability
|
(ii)
|
Defined contribution plans
|
(j)
|
Provisions
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(j)
|
Provisions (continued)
|
(k)
|
Revenue
|
|
·
|
the deliverable has standalone value to the customer; and
|
|
·
|
the fair value of the deliverable can be measured reliably.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(k)
|
Revenue (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(k)
|
Revenue (continued)
|
(l)
|
Lease payments
|
(m)
|
Finance income and costs
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(n)
|
Transactions with related parties
|
(o)
|
Income taxes
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(p)
|
Earnings per share
|
(q)
|
Operating segment
|
(r)
|
Subscriber acquisition costs
|
|
·
|
the capitalized costs can be measured reliably;
|
|
·
|
there is a contract binding the customer for a specific period of time; and
|
|
·
|
it is probable that the amount of the capitalized costs will be recovered through revenue generated by the service contract, or, where the customer withdraws from the contract in advance, through the collection of the penalty.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(s)
|
Government grants
|
(t)
|
Investment property
|
(i)
|
Depreciation
|
Investment Property
|
45 years
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(u)
|
New standards and interpretations
|
(i)
|
Amendments to IFRSs affecting amounts reported and/or disclosures in the financial statements
|
(ii)
|
New and Revised IFRSs applied with no material effect on the consolidated financial statements
|
Amendments to IFRS 10, 12, IAS 27
|
Investment Entities1
|
Amendments to IAS 32
|
Offsetting Financial Assets and Financial Liabilities1
|
Amendments to IAS 36
|
Recoverable Amount Disclosures for Non-Financial Assets1
|
Amendments to IAS 39
|
Novation of Derivatives and Continuation of Hedge Accounting1
|
IFRIC 21
|
Levies1
|
(ii)
|
New and Revised IFRSs applied with no material effect on the consolidated financial statements (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(u)
|
New standards and interpretations
|
(ii)
|
New and Revised IFRSs applied with no material effect on the consolidated financial statements (continued)
|
(iii)
|
New and revised IFRSs in issue but not yet effective
|
IFRS 9
|
Financial Instruments 5
|
Amendments to IAS 19
|
|
Annual Improvements to 2010-2012 Cycle
|
IFRS 2, IFRS 3, IFRS 8, IFRS 13, IAS 16 and IAS 38, IAS 24 1
|
Annual Improvements to 2011-2013 Cycle
|
IFRS 1, IFRS 3, IFRS 13, IAS 40 1
|
IFRS 14
|
Regulatory Deferral Accounts 2
|
Amendments to IFRS 11
|
Accounting for Acquisition of Interests in Joint operations 2
|
Amendments to IAS 16 and IAS 38
|
Clarification of Acceptable Methods of Depreciation and Amortisation 2
|
Amendments to IAS 16 and IAS 41
|
Agriculture: Bearer Plants 2
|
IFRS 15
|
Revenue from Contracts with Customers 4
|
Amendments to IAS 27
|
|
Amendments to IAS 10 and IAS 28
|
|
Annual Improvements to 2012-2014 Cycle
|
IFRS 5, IFRS 7, IAS 9, IAS 34 3
|
Amendments to IAS 1
|
Disclosure Initiative 2
|
Amendments to IFRS 10, IFRS 12 and IAS 28
|
Investment Entities: Applying the Consolidation Exception 2
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(u)
|
New standards and interpretations (continued)
|
(iii)
|
New and revised IFRSs in issue but not yet effective (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(u)
|
New standards and interpretations (continued)
|
(iii)
|
New and revised IFRSs in issue but not yet effective (continued)
|
|
·
|
apply all of the business combinations accounting principles in IFRS 3 and other IFRSs, except for those principles that conflict with the guidance in IFRS 11.
|
|
·
|
disclose the information required by IFRS 3 and other IFRSs for business combinations.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(u)
|
New standards and interpretations (continued)
|
(iii)
|
New and revised IFRSs in issue but not yet effective (continued)
|
|
·
|
Identify the contract with the customer,
|
|
·
|
Identify the performance obligations in the contract,
|
|
·
|
Determine the transaction price,
|
|
·
|
Allocate the transaction price to the performance obligations in the contracts,
|
|
·
|
Recognise revenue when the entity satisfies a performance obligation.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(u)
|
New standards and interpretations (continued)
|
(iii)
|
New and revised IFRSs in issue but not yet effective (continued)
|
|
·
|
The exemption from preparing consolidated financial statements for an intermediate parent entity is available to a parent entity that is a subsidiary of an investment entity, even if the investment entity measures all of its subsidiaries at fair value.
|
|
·
|
A subsidiary that provides services related to the parent’s investment activities should not be consolidated if the subsidiary itself is an investment entity.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
3.
|
Significant accounting policies (continued)
|
(u)
|
New standards and interpretations (continued)
|
(iii)
|
New and revised IFRSs in issue but not yet effective (continued)
|
|
·
|
When applying the equity method to an associate or a joint venture, a non-investment entity investor in an investment entity may retain the fair value measurement applied by the associate or joint venture to its interests in subsidiaries.
|
|
·
|
An investment entity measuring all of its subsidiaries at fair value provides the disclosures relating to investment entities required by IFRS 12.
|
4.
|
Determination of fair values
|
(i)
|
Property, plant and equipment
|
(ii)
|
Intangible assets
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
4.
|
Determination of fair values (continued)
|
(ii)
|
Intangible assets (continued)
|
(iii)
|
Investments in equity and debt securities
|
(iv)
|
Trade and other receivables / due from related parties
|
(v)
|
Derivatives
|
(vi)
|
Non-derivative financial liabilities
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
5.
|
Financial risk management
|
|
·
|
Credit risk
|
|
·
|
Liquidity risk
|
|
·
|
Market risk
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
5.
|
Financial risk management (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
5.
|
Financial risk management (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
6.
|
Operating Segments
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
6.
|
Operating segments (continued)
|
Turkcell
|
Euroasia
|
Belarusian Telecom
|
Superonline
|
Other
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
|||||||||||||||||||||||||||||||||||||
Total external revenue
|
4,265,853 | 4,759,649 | 344,492 | 445,394 | 65,482 | 70,607 | 443,480 | 359,367 | 393,547 | 340,390 | 5,512,854 | 5,975,407 | ||||||||||||||||||||||||||||||||||||
Intersegment revenue
|
27,290 | 30,247 | 2,691 | 4,402 | 108 | 87 | 130,102 | 124,181 | 414,517 | 361,084 | 574,708 | 520,001 | ||||||||||||||||||||||||||||||||||||
Reportable segment adjusted EBITDA
|
1,341,431 | 1,485,098 | 106,294 | 137,119 | 264 | (3,253 | ) | 149,767 | 124,587 | 148,047 | 147,319 | 1,745,803 | 1,890,870 | |||||||||||||||||||||||||||||||||||
Finance income
|
407,886 | 370,809 | 1,690 | 2,730 | 4,176 | 6,111 | 6,348 | 8,274 | 67,698 | 72,638 | 487,798 | 460,562 | ||||||||||||||||||||||||||||||||||||
Finance cost
|
90,317 | 61,119 | (507,635 | ) | (57,425 | ) | (161,984 | ) | (104,607 | ) | (33,078 | ) | (48,547 | ) | (59,846 | ) | (66,277 | ) | (672,226 | ) | (215,737 | ) | ||||||||||||||||||||||||||
Monetary gain
|
- | - | - | - | 88,252 | 82,755 | - | - | 181 | 116 | 88,433 | 82,871 | ||||||||||||||||||||||||||||||||||||
Depreciation and amortization
|
(462,445 | ) | (491,807 | ) | (85,628 | ) | (116,235 | ) | (41,921 | ) | (77,735 | ) | (110,333 | ) | (97,390 | ) | (69,766 | ) | (67,191 | ) | (770,093 | ) | (850,358 | ) | ||||||||||||||||||||||||
Share of profit of equity accounted investees
|
- | - | - | - | - | - | - | - | 96,596 | 155,362 | 96,596 | 155,362 | ||||||||||||||||||||||||||||||||||||
Capital expenditure
|
587,171 | 495,597 | 43,686 | 67,753 | 15,276 | 47,539 | 238,370 | 186,976 | 49,169 | 62,556 | 933,672 | 860,421 | ||||||||||||||||||||||||||||||||||||
Bad debt expense
|
(59,650 | ) | (66,521 | ) | (247 | ) | (512 | ) | (5,267 | ) | (5,525 | ) | (4,943 | ) | (5,445 | ) | (922 | ) | (1,462 | ) | (71,029 | ) | (79,465 | ) | ||||||||||||||||||||||||
Turkcell
|
Euroasia
|
Belarusian Telecom
|
Superonline
|
Other
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||||||||||||||||||||
Total external revenue
|
4,759,649 | 4,844,867 | 445,394 | 402,167 | 70,607 | 62,162 | 359,367 | 270,720 | 340,390 | 285,871 | 5,975,407 | 5,865,787 | ||||||||||||||||||||||||||||||||||||
Inter segment revenue
|
30,247 | 24,820 | 4,402 | 3,250 | 87 | 76 | 124,181 | 111,231 | 361,084 | 323,206 | 520,001 | 462,583 | ||||||||||||||||||||||||||||||||||||
Reportable segment adjusted EBITDA
|
1,485,098 | 1,511,539 | 137,119 | 114,431 | (3,253 | ) | (5,392 | ) | 124,587 | 79,480 | 147,319 | 138,671 | 1,890,870 | 1,838,729 | ||||||||||||||||||||||||||||||||||
Finance income
|
370,809 | 369,198 | 2,730 | 2,468 | 6,111 | 572 | 8,274 | 3,371 | 72,638 | 66,507 | 460,562 | 442,116 | ||||||||||||||||||||||||||||||||||||
Finance cost
|
61,119 | (55,669 | ) | (57,425 | ) | (56,723 | ) | (104,607 | ) | (66,162 | ) | (48,547 | ) | 1,726 | (66,277 | ) | (50,617 | ) | (215,737 | ) | (227,445 | ) | ||||||||||||||||||||||||||
Monetary gain
|
- | - | - | - | 82,755 | 95,322 | - | - | 116 | 3 | 82,871 | 95,325 | ||||||||||||||||||||||||||||||||||||
Depreciation and amortization
|
(491,807 | ) | (506,220 | ) | (116,235 | ) | (116,939 | ) | (77,735 | ) | (46,275 | ) | (97,390 | ) | (69,786 | ) | (67,191 | ) | (67,571 | ) | (850,358 | ) | (806,791 | ) | ||||||||||||||||||||||||
Share of profit of equity accounted investees
|
- | - | - | - | - | - | - | - | 155,362 | 121,733 | 155,362 | 121,733 | ||||||||||||||||||||||||||||||||||||
Capital expenditure
|
495,597 | 531,433 | 67,753 | 77,911 | 47,539 | 53,411 | 186,976 | 253,425 | 62,556 | 66,987 | 860,421 | 983,167 | ||||||||||||||||||||||||||||||||||||
Bad debt expense
|
(66,521 | ) | (55,936 | ) | (512 | ) | (191 | ) | (5,525 | ) | (1,838 | ) | (5,445 | ) | (3,162 | ) | (1,462 | ) | (1,304 | ) | (79,465 | ) | (62,431 | ) | ||||||||||||||||||||||||
Impairment on equity accounted investees
|
- | - | - | - | - | - | - | - | - | 40,250 | - | 40,250 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
6.
|
Operating segments (continued)
|
As at 31 December 2014 and 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||
Turkcell
|
Euroasia
|
Belarusian Telecom
|
Superonline
|
Other
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
|||||||||||||||||||||||||||||||||||||
Reportable segment assets
|
4,160,776 | 3,825,648 | 219,507 | 455,918 | 157,132 | 198,722 | 1,075,401 | 990,172 | 374,723 | 360,868 | 5,987,539 | 5,831,328 | ||||||||||||||||||||||||||||||||||||
Investment in associates
|
- | - | - | - | - | - | - | - | 287,869 | 250,959 | 287,869 | 250,959 | ||||||||||||||||||||||||||||||||||||
Reportable segment liabilities
|
867,152 | 970,443 | 61,884 | 97,841 | 31,492 | 59,222 | 142,132 | 104,367 | 221,594 | 179,335 | 1,324,254 | 1,411,208 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
6.
|
Operating segments (continued)
|
2014
|
2013
|
2012
|
||||||||||
Revenue
|
||||||||||||
Total revenue for reportable segments
|
5,279,498 | 5,793,934 | 5,719,293 | |||||||||
Other revenue
|
808,064 | 701,474 | 609,077 | |||||||||
Elimination of inter-segment revenue
|
(574,708 | ) | (520,001 | ) | (462,583 | ) | ||||||
Consolidated revenue
|
5,512,854 | 5,975,407 | 5,865,787 |
2014
|
2013
|
2012
|
||||||||||
Adjusted EBITDA
|
||||||||||||
Total adjusted EBITDA for reportable segments
|
1,597,756 | 1,743,551 | 1,700,058 | |||||||||
Other adjusted EBITDA
|
148,047 | 147,319 | 138,671 | |||||||||
Elimination of inter-segment adjusted EBITDA
|
(20,623 | ) | (32,823 | ) | (30,283 | ) | ||||||
Consolidated adjusted EBITDA
|
1,725,180 | 1,858,047 | 1,808,446 | |||||||||
Finance income
|
437,519 | 395,396 | 386,088 | |||||||||
Finance costs
|
(559,366 | ) | (95,515 | ) | (125,510 | ) | ||||||
Monetary gain
|
88,433 | 82,871 | 95,325 | |||||||||
Other income
|
27,121 | 18,243 | 18,094 | |||||||||
Other expense
|
(62,654 | ) | (47,464 | ) | (76,924 | ) | ||||||
Share of profit of equity accounted investees
|
96,596 | 155,362 | 121,733 | |||||||||
Depreciation and amortization
|
(747,666 | ) | (826,780 | ) | (788,632 | ) | ||||||
Consolidated profit before income tax
|
1,005,163 | 1,540,160 | 1,438,620 | |||||||||
Income tax expense
|
(334,578 | ) | (310,696 | ) | (291,491 | ) | ||||||
Profit for the period
|
670,585 | 1,229,464 | 1,147,129 |
2014
|
2013
|
2012
|
||||||||||
Finance income
|
||||||||||||
Total finance income for reportable segments
|
420,100 | 387,924 | 375,609 | |||||||||
Other finance income
|
67,698 | 72,638 | 66,507 | |||||||||
Elimination of inter-segment finance income
|
(50,279 | ) | (65,166 | ) | (56,028 | ) | ||||||
Consolidated finance income
|
437,519 | 395,396 | 386,088 |
2014
|
2013
|
2012
|
||||||||||
Finance costs
|
||||||||||||
Total finance costs for reportable segments
|
612,380 | 149,460 | 176,828 | |||||||||
Other finance costs
|
59,846 | 66,277 | 50,617 | |||||||||
Elimination of inter-segment finance costs
|
(112,860 | ) | (120,222 | ) | (101,935 | ) | ||||||
Consolidated finance costs
|
559,366 | 95,515 | 125,510 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
6.
|
Operating segments (continued)
|
2014
|
2013
|
2012
|
||||||||||
Depreciation and amortization
|
||||||||||||
Total depreciation and amortization for reportable segments
|
700,327 | 783,167 | 739,220 | |||||||||
Other depreciation and amortization
|
69,766 | 67,191 | 67,571 | |||||||||
Elimination of inter-segment depreciation and amortization
|
(22,427 | ) | (23,578 | ) | (18,159 | ) | ||||||
Consolidated depreciation and amortization
|
747,666 | 826,780 | 788,632 | |||||||||
2014
|
2013
|
2012
|
||||||||||
Capital expenditure
|
||||||||||||
Total capital expenditure for reportable segments
|
884,503 | 797,865 | 916,180 | |||||||||
Other capital expenditure
|
49,169 | 62,556 | 66,987 | |||||||||
Elimination of inter-segment capital expenditure
|
(8,753 | ) | (6,613 | ) | (7,712 | ) | ||||||
Consolidated capital expenditure
|
924,919 | 853,808 | 975,455 |
2014
|
2013
|
|||||||
Assets
|
||||||||
Total assets for reportable segments
|
5,612,816 | 5,470,460 | ||||||
Other assets
|
374,723 | 360,868 | ||||||
Investments in equity accounted investees
|
287,869 | 250,959 | ||||||
Other unallocated assets
|
3,942,459 | 3,890,351 | ||||||
Consolidated total assets
|
10,217,867 | 9,972,638 |
2014
|
2013
|
|||||||
Liabilities
|
||||||||
Total liabilities for reportable segments
|
1,102,660 | 1,231,873 | ||||||
Other liabilities
|
221,594 | 179,335 | ||||||
Other unallocated liabilities
|
1,687,332 | 1,657,464 | ||||||
Consolidated total liabilities
|
3,011,586 | 3,068,672 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
6.
|
Operating Segments (continued)
|
Revenue
|
2014
|
2013
|
2012
|
|||||||||
Turkey
|
4,918,179 | 5,286,551 | 5,267,145 | |||||||||
Ukraine
|
350,053 | 454,692 | 407,218 | |||||||||
Belarus
|
65,482 | 70,607 | 62,162 | |||||||||
Turkish Republic of Northern Cyprus
|
62,289 | 66,157 | 64,335 | |||||||||
Azerbaijan
|
82,115 | 68,162 | 41,934 | |||||||||
Germany
|
34,736 | 29,238 | 22,993 | |||||||||
5,512,854 | 5,975,407 | 5,865,787 |
2014
|
2013
|
|||||||
Non-current assets
|
||||||||
Turkey
|
3,779,525 | 3,543,214 | ||||||
Ukraine
|
212,014 | 467,779 | ||||||
Belarus
|
124,565 | 161,456 | ||||||
Turkish Republic of Northern Cyprus
|
44,877 | 46,176 | ||||||
Azerbaijan
|
4,609 | 4,959 | ||||||
Germany
|
46 | 4,415 | ||||||
Unallocated non-current assets
|
313,429 | 289,258 | ||||||
4,479,065 | 4,517,257 |
7.
|
Acquisition of subsidiaries
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
7.
|
Acquisition of subsidiaries (continued)
|
Pre-acquisition carrying amounts
|
Fair value adjustments
|
Recognized values on acquisition
|
||||||||||
Property, plant and equipment
|
17,808 | (12,283 | ) | 5,525 | ||||||||
Intangible assets
|
248 | 320 | 568 | |||||||||
Other non-current assets
|
2,421 | - | 2,421 | |||||||||
Deferred tax assets
|
2,889 | 2,392 | 5,281 | |||||||||
Trade receivables and accrued income
|
915 | - | 915 | |||||||||
Other current assets
|
425 | - | 425 | |||||||||
Cash and cash equivalents
|
204 | - | 204 | |||||||||
Loans and borrowings-non current
|
(411 | ) | - | (411 | ) | |||||||
Loans and borrowings-current
|
(673 | ) | - | (673 | ) | |||||||
Trade and other payables
|
(953 | ) | - | (953 | ) | |||||||
Net identifiable assets and liabilities
|
22,873 | (9,571 | ) | 13,302 | ||||||||
Present value of the acquisition consideration
|
12,350 | |||||||||||
Less: fair value of identifiable net assets acquired
|
(13,302 | ) | ||||||||||
Bargain purchase gain on acquisition
|
(952 | ) | ||||||||||
Consideration paid in cash
|
(12,076 | ) | ||||||||||
Add: cash and cash equivalent balances acquired
|
204 | |||||||||||
Net cash and cash equivalent effect of the business combination
|
(11,872 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
8.
|
Revenue
|
2014
|
2013
|
2012
|
||||||||||
Communication fees
|
4,779,343 | 5,369,036 | 5,373,986 | |||||||||
Revenue from betting business
|
82,115 | 68,162 | 41,934 | |||||||||
Call center revenue
|
75,812 | 57,779 | 44,944 | |||||||||
Commission fees on betting business
|
53,954 | 52,236 | 47,087 | |||||||||
Monthly fixed fees
|
23,593 | 39,976 | 50,649 | |||||||||
Simcard sales
|
14,566 | 15,605 | 18,302 | |||||||||
Other revenue (*)
|
483,471 | 372,613 | 288,885 | |||||||||
5,512,854 | 5,975,407 | 5,865,787 |
9.
|
Other income and expenses
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
10.
|
Personnel expenses
|
2014
|
2013
|
2012
|
||||||||||
Wages and salaries (*)
|
542,179 | 590,637 | 548,896 | |||||||||
Increase in liability for long-service leave (**)
|
14,835 | 14,989 | 16,786 | |||||||||
Contributions to defined contribution plans
|
3,602 | 3,438 | 3,737 | |||||||||
560,616 | 609,064 | 569,419 |
11.
|
Finance income and costs
|
2014
|
2013
|
2012
|
||||||||||
Interest income on bank deposits
|
298,160 | 266,372 | 289,768 | |||||||||
Interest income on late payment and contracted receivables
|
130,851 | 113,992 | 91,250 | |||||||||
Premium income on option contracts
|
1,274 | 484 | 2,250 | |||||||||
Discount interest income
|
4,859 | 11,807 | 1,938 | |||||||||
Other interest income
|
2,375 | 2,741 | 882 | |||||||||
Finance income
|
437,519 | 395,396 | 386,088 | |||||||||
Net foreign exchange loss
|
(498,382 | ) | (32,369 | ) | (2,388 | ) | ||||||
Interest expense on financial liabilities measured at amortized cost
|
(53,841 | ) | (54,977 | ) | (93,396 | ) | ||||||
Litigation late payment interest expense
|
(3,171 | ) | (1,949 | ) | (18,996 | ) | ||||||
Option premium expense
|
(15 | ) | (106 | ) | (280 | ) | ||||||
Other
|
(3,957 | ) | (6,114 | ) | (10,450 | ) | ||||||
Finance cost
|
(559,366 | ) | (95,515 | ) | (125,510 | ) | ||||||
Net finance income / (loss)
|
(121,847 | ) | 299,881 | 260,578 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
11.
|
Finance income and costs (continued)
|
12.
|
Income tax expense
|
2014
|
2013
|
2012
|
||||||||||
Current tax expense
|
||||||||||||
Current period
|
(324,656 | ) | (340,944 | ) | (314,853 | ) | ||||||
Deferred tax benefit
|
||||||||||||
Origination and reversal of temporary differences
|
(11,462 | ) | 10,291 | 7,731 | ||||||||
Benefit of investment incentives recognized
|
1,367 | 989 | 878 | |||||||||
Utilization of previously unrecognized tax losses
|
173 | 18,968 | 14,753 | |||||||||
(9,922 | ) | 30,248 | 23,362 | |||||||||
(334,578 | ) | (310,696 | ) | (291,491 | ) |
Income tax recognized directly in equity
2014
|
Before tax
|
Tax (expense)/
benefit
|
Net of tax
|
|||||||||
Foreign currency translation differences
|
(399,175 | ) | (937 | ) | (400,112 | ) | ||||||
Change in cash flow hedge reserve
|
538 | - | 538 | |||||||||
Change in actuarial gain / (loss)
|
(360 | ) | 88 | (272 | ) | |||||||
(398,997 | ) | (849 | ) | (399,846 | ) | |||||||
2013
|
||||||||||||
Foreign currency translation differences
|
(1,405,792 | ) | 3,170 | (1,402,622 | ) | |||||||
Change in cash flow hedge reserve
|
471 | - | 471 | |||||||||
Change in actuarial gain / (loss)
|
2,478 | (482 | ) | 1,996 | ||||||||
(1,402,843 | ) | 2,688 | (1,400,155 | ) | ||||||||
2012
|
||||||||||||
Foreign currency translation differences
|
312,708 | 2,145 | 314,853 | |||||||||
Change in cash flow hedge reserve
|
(860 | ) | - | (860 | ) | |||||||
Change in actuarial (loss) / gain
|
(4,911 | ) | 960 | (3,951 | ) | |||||||
306,937 | 3,105 | 310,042 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
12.
|
Income tax expense (continued)
|
2014
|
2013
|
2012
|
||||||||||||||||||||||
Profit for the year
|
670,585 | 1,229,464 | 1,147,129 | |||||||||||||||||||||
Total income tax expense
|
334,578 | 310,696 | 291,491 | |||||||||||||||||||||
Profit before income tax
|
1,005,163 | 1,540,160 | 1,438,620 | |||||||||||||||||||||
Income tax using the Company’s domestic tax rate
|
20 | % | (201,033 | ) | 20 | % | (308,032 | ) | 20 | % | (287,724 | ) | ||||||||||||
Effect of tax rates in foreign jurisdictions
|
2 | % | (23,625 | ) | 1 | % | (12,093 | ) | - | (5,854 | ) | |||||||||||||
Tax exempt income
|
- | 2,687 | - | 1,161 | - | 3,340 | ||||||||||||||||||
Non-deductible expenses
|
3 | % | (33,201 | ) | 1 | % | (22,432 | ) | 3 | % | (43,939 | ) | ||||||||||||
Tax incentives
|
- | 1,367 | - | 989 | - | 878 | ||||||||||||||||||
Utilization of previously unrecognized tax losses
|
- | 173 | (1 | )% | 18,968 | (1 | )% | 14,753 | ||||||||||||||||
Unrecognized deferred tax assets
|
12 | % | (116,817 | ) | 2 | % | (34,349 | ) | 1 | % | (8,511 | ) | ||||||||||||
Difference in effective tax rate of equity accounted investees
|
(1 | )% | 13,935 | (2 | )% | 23,482 | (1 | )% | 21,435 | |||||||||||||||
Other
|
(2 | )% | 21,936 | (1 | )% | 21,610 | (1 | )% | 14,131 | |||||||||||||||
Total income tax expense
|
(334,578 | ) | (310,696 | ) | (291,491 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
13.
|
Property, plant and equipment
|
Cost or deemed cost
|
Balance as at
1 January 2014 |
Additions
|
Disposals
|
Transfers
|
Impairment
|
Acquisitions through business combinations
|
Effect of movements in exchange rates and hyperinflation
|
Balance as at
31 December 2014 |
||||||||||||||||||||||||
Network infrastructure (All operational)
|
5,214,435 | 99,451 | (363,445 | ) | 542,406 | - | 4,879 | (789,127 | ) | 4,708,599 | ||||||||||||||||||||||
Land and buildings
|
237,132 | 10,968 | - | 35 | - | - | (25,304 | ) | 222,831 | |||||||||||||||||||||||
Equipment, fixtures and fittings
|
247,806 | 23,012 | (3,955 | ) | 1,022 | - | 282 | (24,764 | ) | 243,403 | ||||||||||||||||||||||
Motor vehicles
|
16,441 | 988 | (644 | ) | 91 | - | - | (1,435 | ) | 15,441 | ||||||||||||||||||||||
Leasehold improvements
|
109,397 | 1,805 | (2,770 | ) | 189 | - | - | (10,070 | ) | 98,551 | ||||||||||||||||||||||
Construction in progress
|
248,083 | 539,916 | (1,558 | ) | (557,532 | ) | (974 | ) | 364 | (36,743 | ) | 191,556 | ||||||||||||||||||||
Total
|
6,073,294 | 676,140 | (372,372 | ) | (13,789 | ) | (974 | ) | 5,525 | (887,443 | ) | 5,480,381 | ||||||||||||||||||||
Accumulated depreciation
|
||||||||||||||||||||||||||||||||
Network infrastructure (All operational)
|
2,914,030 | 456,747 | (358,689 | ) | - | 37,275 | - | (504,937 | ) | 2,544,426 | ||||||||||||||||||||||
Land and buildings
|
101,857 | 8,315 | - | - | - | - | (10,537 | ) | 99,635 | |||||||||||||||||||||||
Equipment, fixtures and fittings
|
205,910 | 16,304 | (3,642 | ) | - | 23 | - | (21,907 | ) | 196,688 | ||||||||||||||||||||||
Motor vehicles
|
12,731 | 1,745 | (604 | ) | - | 10 | - | (1,111 | ) | 12,771 | ||||||||||||||||||||||
Leasehold improvements
|
90,953 | 5,044 | (2,312 | ) | - | 7 | - | (8,378 | ) | 85,314 | ||||||||||||||||||||||
Total
|
3,325,481 | 488,155 | (365,247 | ) | - | 37,315 | - | (546,870 | ) | 2,938,834 | ||||||||||||||||||||||
Total property, plant and Equipment
|
2,747,813 | 187,985 | (7,125 | ) | (13,789 | ) | (38,289 | ) | 5,525 | (340,573 | ) | 2,541,547 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
13.
|
Property, plant and equipment (continued)
|
Cost or deemed cost
|
Balance as at 1
January 2013 |
Additions
|
Disposals
|
Transfers
|
Impairment
|
Acquisitions through business combinations
|
Effect of movements in exchange rates and hyperinflation
|
Transfer to Investment Property
|
Balance as at 31
December 2013 |
|||||||||||||||||||||||||||
Network infrastructure (All operational)
|
5,836,623 | 96,505 | (478,198 | ) | 505,108 | - | 568 | (746,171 | ) | - | 5,214,435 | |||||||||||||||||||||||||
Land and buildings
|
267,728 | 7,156 | - | 3,628 | - | - | (41,380 | ) | - | 237,132 | ||||||||||||||||||||||||||
Equipment, fixtures and fittings
|
273,436 | 19,695 | (4,888 | ) | 1,761 | - | 33 | (42,231 | ) | - | 247,806 | |||||||||||||||||||||||||
Motor vehicles
|
17,915 | 1,348 | (705 | ) | 288 | - | - | (2,405 | ) | - | 16,441 | |||||||||||||||||||||||||
Leasehold improvements
|
123,661 | 9,909 | (139 | ) | 5,028 | - | - | (19,050 | ) | (10,012 | ) | 109,397 | ||||||||||||||||||||||||
Construction in progress
|
281,123 | 508,050 | (1,773 | ) | (516,768 | ) | (1,686 | ) | - | (20,863 | ) | - | 248,083 | |||||||||||||||||||||||
Total
|
6,800,486 | 642,663 | (485,703 | ) | (955 | ) | (1,686 | ) | 601 | (872,100 | ) | (10,012 | ) | 6,073,294 | ||||||||||||||||||||||
Accumulated depreciation
|
||||||||||||||||||||||||||||||||||||
Network infrastructure (All operational)
|
3,276,644 | 520,507 | (477,241 | ) | - | 38,564 | - | (444,444 | ) | - | 2,914,030 | |||||||||||||||||||||||||
Land and buildings
|
111,538 | 9,105 | - | - | 314 | - | (19,100 | ) | - | 101,857 | ||||||||||||||||||||||||||
Equipment, fixtures and fittings
|
231,696 | 13,244 | (4,848 | ) | - | 261 | - | (34,443 | ) | - | 205,910 | |||||||||||||||||||||||||
Motor vehicles
|
13,286 | 1,926 | (665 | ) | - | - | - | (1,816 | ) | - | 12,731 | |||||||||||||||||||||||||
Leasehold improvements
|
106,123 | 4,157 | (119 | ) | - | - | - | (17,300 | ) | (1,908 | ) | 90,953 | ||||||||||||||||||||||||
Total
|
3,739,287 | 548,939 | (482,873 | ) | - | 39,139 | - | (517,103 | ) | (1,908 | ) | 3,325,481 | ||||||||||||||||||||||||
Total property, plant and Equipment
|
3,061,199 | 93,724 | (2,830 | ) | (955 | ) | (40,825 | ) | 601 | (354,997 | ) | (8,104 | ) | 2,747,813 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
13.
|
Property, plant and equipment (continued)
|
14.
|
Intangible assets
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
14.
|
Intangible assets (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
14.
|
Intangible assets (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
14.
|
Intangible assets (continued)
|
Cost
|
Balance at 1 January 2014
|
Additions
|
Disposals
|
Transfers
|
Impairment
|
Acquisitions through business combinations
|
Effects of movements in exchange rates and hyperinflation
|
Balance at
31 December 2014
|
||||||||||||||||||||||||
GSM and other telecommunication operating licenses
|
1,112,175 | 5,014 | (529 | ) | 3,191 | (112,985 | ) | 1,006,866 | ||||||||||||||||||||||||
Computer software
|
1,988,791 | 170,770 | (771 | ) | 68,787 | - | 67 | (187,688 | ) | 2,039,956 | ||||||||||||||||||||||
Transmission lines
|
24,398 | 4,672 | - | - | - | - | (1,993 | ) | 27,077 | |||||||||||||||||||||||
Central betting system operating right
|
5,372 | 261 | - | - | - | - | (563 | ) | 5,070 | |||||||||||||||||||||||
Indefeasible right of usage (*)
|
18,488 | 1,049 | (39 | ) | - | - | - | (1,329 | ) | 18,169 | ||||||||||||||||||||||
Brand name
|
3,298 | - | - | - | - | - | (263 | ) | 3,035 | |||||||||||||||||||||||
Customer base
|
6,758 | - | - | - | - | 501 | (566 | ) | 6,693 | |||||||||||||||||||||||
Goodwill
|
15,384 | - | - | - | - | - | (1,225 | ) | 14,159 | |||||||||||||||||||||||
Other
|
2,603 | 3,108 | - | 4,598 | - | - | (662 | ) | 9,647 | |||||||||||||||||||||||
Construction in progress
|
1,321 | 63,470 | - | (62,787 | ) | - | - | (532 | ) | 1,472 | ||||||||||||||||||||||
Total
|
3,178,588 | 248,344 | (1,339 | ) | 13,789 | - | 568 | (307,806 | ) | 3,132,144 | ||||||||||||||||||||||
Accumulated amortization
|
||||||||||||||||||||||||||||||||
GSM and other telecommunication operating licenses
|
590,110 | 48,451 | (529 | ) | - | 4,522 | - | (67,828 | ) | 574,726 | ||||||||||||||||||||||
Computer software
|
1,444,651 | 161,988 | (168 | ) | (325 | ) | 428 | - | (143,100 | ) | 1,463,474 | |||||||||||||||||||||
Transmission lines
|
22,380 | 404 | - | - | - | - | (1,856 | ) | 20,928 | |||||||||||||||||||||||
Central betting system operating right
|
3,892 | 364 | - | - | - | - | (467 | ) | 3,789 | |||||||||||||||||||||||
Indefeasible right of usage
|
4,406 | 1,293 | - | - | - | - | (286 | ) | 5,413 | |||||||||||||||||||||||
Brand name
|
1,731 | 322 | - | - | - | - | (156 | ) | 1,897 | |||||||||||||||||||||||
Customer base
|
3,434 | 627 | - | - | - | - | (310 | ) | 3,751 | |||||||||||||||||||||||
Other
|
1,113 | 1,531 | - | 325 | - | - | (214 | ) | 2,755 | |||||||||||||||||||||||
Total
|
2,071,717 | 214,980 | (697 | ) | - | 4,950 | - | (214,217 | ) | 2,076,733 | ||||||||||||||||||||||
Total intangible assets
|
1,106,871 | 33,364 | (642 | ) | 13,789 | (4,950 | ) | 568 | (93,589 | ) | 1,055,411 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
14.
|
Intangible assets (continued)
|
Cost
|
Balance at 1 January 2013
|
Additions
|
Disposals
|
Transfers
|
Impairment
|
Acquisitions through business combinations
|
Effects of movements in exchange rates and hyperinflation
|
Balance at
31 December 2013
|
||||||||||||||||||||||||
GSM and other telecommunication operating licenses
|
1,271,274 | 2,811 | - | 414 | - | - | (162,324 | ) | 1,112,175 | |||||||||||||||||||||||
Computer software
|
2,113,345 | 142,891 | (4,817 | ) | 67,600 | - | - | (330,228 | ) | 1,988,791 | ||||||||||||||||||||||
Transmission lines
|
28,569 | 526 | - | - | - | - | (4,697 | ) | 24,398 | |||||||||||||||||||||||
Central betting system operating right
|
5,966 | 280 | - | - | - | - | (874 | ) | 5,372 | |||||||||||||||||||||||
Indefeasible right of usage
|
19,541 | 2,289 | - | - | - | - | (3,342 | ) | 18,488 | |||||||||||||||||||||||
Brand name
|
3,949 | - | - | - | - | - | (651 | ) | 3,298 | |||||||||||||||||||||||
Customer base
|
7,959 | - | - | - | - | 117 | (1,318 | ) | 6,758 | |||||||||||||||||||||||
Goodwill
|
18,419 | - | - | - | - | - | (3,035 | ) | 15,384 | |||||||||||||||||||||||
Other
|
2,746 | 98 | - | - | 5 | (246 | ) | 2,603 | ||||||||||||||||||||||||
Construction in progress
|
1,739 | 66,641 | - | (67,059 | ) | - | - | - | 1,321 | |||||||||||||||||||||||
Total
|
3,473,507 | 215,536 | (4,817 | ) | 955 | - | 122 | (506,715 | ) | 3,178,588 | ||||||||||||||||||||||
Accumulated amortization
|
||||||||||||||||||||||||||||||||
GSM and other telecommunication operating licenses
|
592,580 | 53,485 | - | - | 10,237 | - | (66,192 | ) | 590,110 | |||||||||||||||||||||||
Computer software
|
1,544,898 | 164,673 | (4,186 | ) | - | 4,823 | - | (265,557 | ) | 1,444,651 | ||||||||||||||||||||||
Transmission lines
|
25,881 | 834 | - | - | - | - | (4,335 | ) | 22,380 | |||||||||||||||||||||||
Central betting system operating right
|
3,989 | 362 | - | - | - | - | (459 | ) | 3,892 | |||||||||||||||||||||||
Indefeasible right of usage
|
3,785 | 1,388 | - | - | - | - | (767 | ) | 4,406 | |||||||||||||||||||||||
Brand name
|
1,678 | 369 | - | - | - | - | (316 | ) | 1,731 | |||||||||||||||||||||||
Customer base
|
3,455 | 641 | - | - | - | - | (662 | ) | 3,434 | |||||||||||||||||||||||
Other
|
1,124 | 182 | - | - | - | - | (193 | ) | 1,113 | |||||||||||||||||||||||
Total
|
2,177,390 | 221,934 | (4,186 | ) | - | 15,060 | - | (338,481 | ) | 2,071,717 | ||||||||||||||||||||||
Total intangible assets
|
1,296,117 | (6,398 | ) | (631 | ) | 955 | (15,060 | ) | 122 | (168,234 | ) | 1,106,871 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
15.
|
Investment property
|
31 December 2014
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Investment property in Gebze
|
- | - | 5,778 | 5,778 | ||||||||||||
31 December 2013
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Investment property in Gebze
|
- | - | 7,757 | 7,757 | ||||||||||||
2014
|
2013
|
|||||||
Cost value | ||||||||
Opening balance
|
9,464 | - | ||||||
Transfer from tangible fixed assets
|
- | 10,012 | ||||||
Effects of movements in exchange rates
|
(753 | ) | (548 | ) | ||||
Ending balance
|
8,711 | 9,464 | ||||||
Accumulated depreciation
|
||||||||
Opening balance
|
(1,825 | ) | - | |||||
Transfer from tangible fixed assets
|
- | (1,908 | ) | |||||
Charge for the year and impairment
|
||||||||
during the year (*)
|
(1,292 | ) | (22 | ) | ||||
Effects of movements in exchange rates
|
184 | 105 | ||||||
Ending balance
|
(2,933 | ) | (1,825 | ) | ||||
Carrying value
|
5,778 | 7,639 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
16.
|
Investments in equity accounted investees
|
Ownership
|
Current
assets
|
Non-current
assets
|
Total
assets
|
Current
liabilities
|
Non-current
liabilities
|
Non-controlling
interest
|
Equity attributable to parent
|
Total liabilities and equity
|
||||||||||||||||||||||||||||
31 December 2014
|
||||||||||||||||||||||||||||||||||||
Fintur (associate)
|
41.45 | % | 659,282 | 1,577,070 | 2,236,352 | 434,472 | 910,381 | 334,584 | 556,915 | 2,236,352 | ||||||||||||||||||||||||||
659,282 | 1,577,070 | 2,236,352 | 434,472 | 910,381 | 334,584 | 556,915 | 2,236,352 | |||||||||||||||||||||||||||||
31 December 2013
|
||||||||||||||||||||||||||||||||||||
Fintur (associate)
|
41.45 | % | 445,717 | 1,828,603 | 2,274,320 | 465,938 | 1,018,142 | 386,975 | 403,265 | 2,274,320 | ||||||||||||||||||||||||||
A-Tel (joint venture)*
|
50.00 | % | 47,145 | - | 47,145 | 13 | 3,443 | - | 43,689 | 47,145 | ||||||||||||||||||||||||||
492,862 | 1,828,603 | 2,321,465 | 465,951 | 1,021,585 | 386,975 | 446,954 | 2,321,465 |
Revenues
|
Profit/loss**
|
Other comprehensive income***
|
Total comprehensive income**
|
||||||||||||||
2014
|
|||||||||||||||||
Fintur
|
1,801,432 | 227,988 | (47,694 | ) | 180,294 | ||||||||||||
A-Tel
|
- | 4,191 | - | 4,191 | |||||||||||||
1,801,432 | 232,179 | (47,694 | ) | 184,485 | |||||||||||||
2013
|
|||||||||||||||||
Fintur
|
2,035,678 | 375,748 | (39,156 | ) | 336,592 | ||||||||||||
A-Tel
|
- | (771 | ) | - | (771 | ) | |||||||||||
2,035,678 | 374,977 | (39,156 | ) | 335,821 | |||||||||||||
2012
|
|||||||||||||||||
Fintur
|
2,027,320 | 344,016 | 9,952 | 353,968 | |||||||||||||
A-Tel
|
27,234 | 23,400 | - | 23,400 | |||||||||||||
2,054,554 | 367,416 | 9,952 | 377,368 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
16.
|
Investments in equity accounted investees (continued)
|
2014
|
2013
|
|||||||
Net assets of Fintur
|
556,915 | 403,265 | ||||||
Proportion of the Group’s ownership interest in Fintur
|
230,841 | 167,153 | ||||||
Goodwill
|
57,028 | 61,961 | ||||||
Carrying amount of the Group’s interest in Fintur
|
287,869 | 229,114 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
16.
|
Investments in equity accounted investees (continued)
|
31 December 2014
|
||||
Share sale price
|
14,306 | |||
Less: carrying amount of investment on the date of sale
|
(14,722 | ) | ||
Loss recognized
|
(416 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
17.
|
Other investments
|
Securities
|
2014
|
2013
|
||||||
Corporate debt securities – held-to-maturity
|
- | 3,851 |
2014
|
2013
|
|||||||
Held to maturity financial assets:
|
||||||||
Corporate debt securities
|
4,832 | 27,028 | ||||||
Available for sale financial assets:
|
||||||||
Time deposits mature over 3 months
|
3,512 | - | ||||||
8,344 | 27,028 |
18.
|
Other non-current assets
|
2014
|
2013
|
|||||||
Advances given for fixed assets
|
101,790 | 2,162 | ||||||
Prepaid expenses
|
56,908 | 38,279 | ||||||
VAT receivable
|
51,697 | 68,036 | ||||||
Deposits and guarantees given
|
7,680 | 7,711 | ||||||
Others
|
8,576 | 1,780 | ||||||
226,651 | 117,968 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
19.
|
Deferred tax assets and liabilities
|
2014
|
2013
|
|||||||
Deductible temporary differences
|
46,529 | 57,496 | ||||||
Tax losses
|
156,290 | 125,794 | ||||||
Total unrecognized deferred tax assets
|
202,819 | 183,290 |
Expiration Date
|
Amount
|
||||||
2015
|
33,964 | ||||||
2016
|
54,995 | ||||||
2017
|
13,678 | ||||||
2018
|
6,661 | ||||||
2019
|
6,100 | ||||||
2021 - 2024 | 230,878 | ||||||
346,276 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
19.
|
Deferred tax assets and liabilities (continued)
|
Assets
|
Liabilities
|
Net
|
||||||||||||||||||||||
2014
|
2013
|
2014
|
2013
|
2014
|
2013
|
|||||||||||||||||||
Property, plant & equipment and intangible assets
|
8,359 | 1,352 | (105,648 | ) | (99,414 | ) | (97,289 | ) | (98,062 | ) | ||||||||||||||
Investment
|
660 | - | (19,583 | ) | (15,868 | ) | (18,923 | ) | (15,868 | ) | ||||||||||||||
Provisions
|
27,681 | 28,362 | - | - | 27,681 | 28,362 | ||||||||||||||||||
Trade and other payables
|
34,140 | 36,711 | (47 | ) | - | 34,093 | 36,711 | |||||||||||||||||
Tax credit carry forwards (Investment tax credit)
|
11,802 | 19,905 | - | - | 11,802 | 19,905 | ||||||||||||||||||
Other items
|
43,008 | 37,348 | (906 | ) | (4,814 | ) | 42,102 | 32,534 | ||||||||||||||||
Tax assets / (liabilities)
|
125,650 | 123,678 | (126,184 | ) | (120,096 | ) | (534 | ) | 3,582 | |||||||||||||||
Net off of tax
|
(100,175 | ) | (89,345 | ) | 100,175 | 89,345 | - | - | ||||||||||||||||
Net tax assets / (liabilities)
|
25,475 | 34,333 | (26,009 | ) | (30,751 | ) | (534 | ) | 3,582 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
19.
|
Deferred tax assets and liabilities (continued)
|
Balance at
1 January 2013
|
Recognized in the statement of profit or loss
|
Recognized in other comprehensive income
|
Acquired in business combinations
|
Effect of movements in exchange rates
|
Balance at
31 December 2013
|
|||||||||||||||||||
Property, plant & equipment and intangible assets
|
(115,118 | ) | 415 | - | (82 | ) | 16,723 | (98,062 | ) | |||||||||||||||
Investment
|
(13,995 | ) | (8,024 | ) | 3,170 | - | 2,981 | (15,868 | ) | |||||||||||||||
Provisions
|
13,070 | 19,052 | - | - | (3,760 | ) | 28,362 | |||||||||||||||||
Trade and other payables
|
42,205 | 1,595 | - | - | (7,089 | ) | 36,711 | |||||||||||||||||
Tax credit carry forward
|
13,368 | 9,545 | - | - | (3,008 | ) | 19,905 | |||||||||||||||||
Other items
|
31,124 | 7,665 | (482 | ) | - | (5,773 | ) | 32,534 | ||||||||||||||||
Total
|
(29,346 | ) | 30,248 | 2,688 | (82 | ) | 74 | 3,582 | ||||||||||||||||
Balance at
1 January 2014
|
Recognized in the statement of profit or loss
|
Recognized in other comprehensive income
|
Acquired in business combinations
|
Effect of movements in exchange rates
|
Balance at
31 December 2014
|
|||||||||||||||||||
Property, plant & equipment and intangible assets
|
(98,062 | ) | (15,010 | ) | - | - | 15,783 | (97,289 | ) | |||||||||||||||
Investment
|
(15,868 | ) | (3,010 | ) | (937 | ) | 892 | (18,923 | ) | |||||||||||||||
Provisions
|
28,362 | 1,727 | - | - | (2,408 | ) | 27,681 | |||||||||||||||||
Trade and other payables
|
36,711 | 333 | - | - | (2,951 | ) | 34,093 | |||||||||||||||||
Tax credit carry forward
|
19,905 | (7,139 | ) | - | - | (964 | ) | 11,802 | ||||||||||||||||
Other items
|
32,534 | 13,177 | 88 | - | (3,697 | ) | 42,102 | |||||||||||||||||
Total
|
3,582 | (9,922 | ) | (849 | ) | - | 6,655 | (534 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
20.
|
Trade receivables and accrued income
|
2014
|
2013
|
|||||||
Undue assigned contracted receivables
|
788,571 | 582,816 | ||||||
Receivables from subscribers
|
474,834 | 445,574 | ||||||
Accounts and checks receivable
|
90,957 | 100,415 | ||||||
Accrued income
|
156,059 | 165,831 | ||||||
1,510,421 | 1,294,636 |
21.
|
Other current assets
|
2014
|
2013
|
|||||||
Prepaid expenses
|
98,667 | 87,166 | ||||||
Amounts to be received from Ministry of Transport, Maritime Affairs and Communications
|
75,457 | 52,475 | ||||||
Prepayment for subscriber acquisition cost
|
36,789 | 25,669 | ||||||
Advances to suppliers
|
17,608 | 13,662 | ||||||
Special communication tax to be collected from subscribers
|
15,474 | 14,467 | ||||||
Interest income accruals
|
10,226 | 14,671 | ||||||
VAT receivable
|
7,260 | 2,319 | ||||||
Receivables from personnel
|
2,263 | 2,978 | ||||||
Receivables from Tax Office
|
185 | 201 | ||||||
Restricted cash
|
- | 43,078 | ||||||
Other
|
24,874 | 25,466 | ||||||
288,803 | 282,152 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
21.
|
Other current assets (continued)
|
22.
|
Cash and cash equivalents
|
2014
|
2013
|
|||||||
Cash in hand
|
106 | 99 | ||||||
Cheques received
|
34 | 84 | ||||||
Banks
|
3,892,611 | 3,806,411 | ||||||
- Demand deposits
|
247,533 | 204,864 | ||||||
- Time deposits
|
3,645,078 | 3,601,547 | ||||||
Bonds and bills
|
2,147 | 2,114 | ||||||
Cash and cash equivalents
|
3,894,898 | 3,808,708 | ||||||
Bank overdrafts
|
- | (237 | ) | |||||
Cash and cash equivalents in the statement of cash flows
|
3,894,898 | 3,808,471 |
23.
|
Capital and reserves
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
23.
|
Capital and reserves (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
23.
|
Capital and reserves (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
24.
|
Earnings per share
|
2014
|
2013
|
2012
|
||||||||||
Numerator:
|
||||||||||||
Net profit for the period attributed to owners
|
864,924 | 1,228,188 | 1,158,835 | |||||||||
Denominator:
|
||||||||||||
Weighted average number of shares
|
2,200,000,000 | 2,200,000,000 | 2,200,000,000 | |||||||||
Basic and diluted earnings per share
|
0.39 | 0.56 | 0.53 |
25.
|
Other non-current liabilities
|
2014
|
2013
|
|||||||
Consideration payable in relation to acquisition of Belarusian Telecom
|
70,394 | 69,054 | ||||||
Accrual for Evrensel Project (Note 34)
|
27,114 | 24,611 | ||||||
Deposits and guarantees taken from agents
|
16,638 | 15,507 | ||||||
Payables to other suppliers
|
- | 4,146 | ||||||
Other
|
19,344 | 14,351 | ||||||
133,490 | 127,669 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
26.
|
Loans and borrowings
|
2014
|
2013
|
|||||||
Non-current liabilities
|
||||||||
Unsecured bank loans
|
519,570 | 693,043 | ||||||
Secured bank loans
|
3,013 | 4,589 | ||||||
Finance lease liabilities
|
15,545 | 18,518 | ||||||
538,128 | 716,150 | |||||||
Current liabilities
|
||||||||
Unsecured bank facility
|
707,153 | 550,134 | ||||||
Current portion of unsecured bank loans
|
325,997 | 272,133 | ||||||
Current portion of secured bank loans
|
20,980 | 20,408 | ||||||
Current portion of finance lease liabilities
|
2,316 | 2,576 | ||||||
Option contracts used for hedging
|
362 | 994 | ||||||
1,056,808 | 846,245 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
26.
|
Loans and borrowings (continued)
|
31 December 2014
|
31 December 2013
|
|||||||||||||||||
Currency
|
Year of maturity
|
Interest rate type
|
Nominal interest rate
|
Face value
|
Carrying amount
|
Nominal interest rate
|
Face value
|
Carrying amount
|
||||||||||
Unsecured bank loans
|
USD
|
2015-2018
|
Floating
|
Libor+0.7%-3.5%
|
1,224,162
|
1,226,770
|
Libor+1.3%-3.5%
|
1,135,637
|
1,138,316
|
|||||||||
Unsecured bank loans
|
USD
|
2015-2016
|
Fixed
|
2.4%-8.0%
|
110,348
|
121,246
|
1.3%-8.0%
|
216,710
|
223,052
|
|||||||||
Unsecured bank loans
|
TL
|
2015-2017
|
Fixed
|
8.3%-10.5%
|
204,494
|
204,704
|
8.3%-10.0%
|
153,306
|
153,942
|
|||||||||
Secured bank loans*
|
EUR
|
2014
|
Floating
|
-
|
-
|
Libor+3.465%
|
16,510
|
18,955
|
||||||||||
Secured bank loans**
|
BYR
|
2020
|
Fixed
|
12-16%
|
3,260
|
4,106
|
12-16%
|
4,739
|
6,042
|
|||||||||
Secured bank loans*
|
USD
|
2015
|
Floating
|
Libor+3.5%
|
17,834
|
19,887
|
-
|
-
|
-
|
|||||||||
Finance lease liabilities
|
EUR
|
2015-2024
|
Fixed
|
3.4%
|
20,771
|
17,545
|
3.35%
|
24,455
|
20,325
|
|||||||||
Finance lease liabilities
|
USD
|
2015
|
Fixed
|
0.7%-8.0%
|
356
|
316
|
0.68%-4.64%
|
839
|
769
|
|||||||||
1,581,225
|
1,594,574
|
1,552,196
|
1,561,401
|
(*)
|
Secured by System Capital Management Limited (“SCM”).
|
(**)
|
Secured by Republic of Belarus Government.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
26.
|
Loans and borrowings (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
26.
|
Loans and borrowings (continued)
|
31 December 2014
|
31 December 2013
|
|||||||||||||||||||||||
Future minimum lease payments
|
Interest
|
Present value of minimum lease payments
|
Future minimum lease payments
|
Interest
|
Present value of minimum lease payments
|
|||||||||||||||||||
Less than one year
|
2,835 | 519 | 2,316 | 3,219 | 643 | 2,576 | ||||||||||||||||||
More than one year
|
18,292 | 2,747 | 15,545 | 22,075 | 3,557 | 18,518 | ||||||||||||||||||
21,127 | 3,266 | 17,861 | 25,294 | 4,200 | 21,094 |
Currency
|
Notional amount
|
Fair value asset / (liability)
|
|||||||||||||||
2014
|
2013
|
2014
|
2013
|
||||||||||||||
Interest collar
|
US$
|
86,000 | 86,000 | (362 | ) | (994 | ) |
27.
|
Employee benefits
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
27.
|
Employee benefits (continued)
|
2014
|
2013
|
|||||||
Opening balance
|
38,709 | 41,452 | ||||||
Provision set/reversed during the period
|
12,857 | 12,961 | ||||||
Actuarial (gain) / loss
|
360 | (2,478 | ) | |||||
Unwind of discount
|
1,978 | 2,028 | ||||||
Effect of change in foreign exchange rate
|
(2,855 | ) | (7,501 | ) | ||||
Payments made during the period
|
(9,530 | ) | (7,753 | ) | ||||
Closing balance
|
41,519 | 38,709 |
28.
|
Deferred income
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
29.
|
Provisions
|
Legal
|
Obligations for dismantling, removing and site restoration
|
Total
|
||||||||||
Balance at 1 January 2013
|
83,764 | 65,130 | 148,894 | |||||||||
Provision made/used during the year
|
896 | 4,494 | 5,390 | |||||||||
Unwind of discount
|
2,506 | 1,700 | 4,206 | |||||||||
Transfer
|
(154 | ) | - | (154 | ) | |||||||
Effect of change in foreign exchange rate
|
(14,161 | ) | (8,651 | ) | (22,812 | ) | ||||||
Balance at 31 December 2013
|
72,851 | 62,673 | 135,524 |
Legal
|
Obligations for dismantling, removing and site restoration
|
Total
|
||||||||||
Balance at 1 January 2014
|
72,851 | 62,673 | 135,524 | |||||||||
Provision made/used during the year
|
355 | (2,108 | ) | (1,753 | ) | |||||||
Unwind of discount
|
2,190 | 1,937 | 4,127 | |||||||||
Transfer
|
194 | - | 194 | |||||||||
Effect of change in foreign exchange rate
|
(6,033 | ) | (12,008 | ) | (18,041 | ) | ||||||
Balance at 31 December 2014
|
69,557 | 50,494 | 120,051 | |||||||||
Legal
|
Bonus
|
Total
|
||||||||||
Balance at 1 January 2013
|
31,013 | 56,119 | 87,132 | |||||||||
Provision made/(reversed) during the year
|
15,873 | 65,302 | 81,175 | |||||||||
Provisions used during the year
|
(19,793 | ) | (52,248 | ) | (72,041 | ) | ||||||
Unwind of discount
|
38 | - | 38 | |||||||||
Transfer
|
154 | - | 154 | |||||||||
Effect of change in foreign exchange rate
|
(4,143 | ) | (10,016 | ) | (14,159 | ) | ||||||
Balance at 31 December 2013
|
23,142 | 59,157 | 82,299 | |||||||||
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
29.
|
Provisions (continued)
|
Legal
|
Bonus
|
Total
|
||||
Balance at 1 January 2014
|
23,142
|
59,157
|
82,299
|
|||
Provision made/(reversed) during the year
|
49,443
|
58,911
|
108,354
|
|||
Provisions used during the year
|
(66,693)
|
(59,846)
|
(126,539)
|
|||
Unwind of discount
|
168
|
-
|
168
|
|||
Transfer
|
(194)
|
-
|
(194)
|
|||
Effect of change in foreign exchange rate
|
(2,368)
|
(5,842)
|
(8,210)
|
|||
Balance at 31 December 2014
|
3,498
|
52,380
|
55,878
|
|||
30.
|
Trade and other payables
|
2014
|
2013
|
|||||||
Payables to suppliers
|
499,536 | 471,007 | ||||||
Taxes and withholdings payable
|
162,883 | 176,544 | ||||||
License fee accrual
|
69,987 | 67,130 | ||||||
Selling and marketing expense accrual
|
59,268 | 61,669 | ||||||
ICTA share accrual
|
12,874 | 13,889 | ||||||
Roaming expense accrual
|
5,913 | 6,846 | ||||||
Other
|
80,963 | 94,430 | ||||||
891,424 | 891,515 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
30.
|
Trade and other payables (continued)
|
31.
|
Financial instruments
|
2014
|
2013
|
|||||||||||
Other non-current assets*
|
18 | 4,216 | - | |||||||||
Other current assets*
|
21 | 17,825 | 58,750 | |||||||||
Cash and cash equivalents**
|
22 | 3,894,792 | 3,808,609 | |||||||||
Trade receivables
|
20 | 1,846,755 | 1,542,459 | |||||||||
Held-to-maturity
|
17 | 4,832 | 30,879 | |||||||||
Available for sale
|
17 | 3,512 | - | |||||||||
Due from related parties-current
|
35 | 5,579 | 10,012 | |||||||||
5,777,511 | 5,450,709 |
2014
|
2013
|
|||||||
Receivable from subscribers
|
1,737,587 | 1,400,226 | ||||||
Receivables from distributors and other operators
|
90,724 | 126,128 | ||||||
Other
|
24,023 | 26,117 | ||||||
1,852,334 | 1,552,471 |
2014
|
2013
|
|||||||
Not past due
|
1,680,682 | 1,356,666 | ||||||
1-30 days past due
|
68,975 | 97,673 | ||||||
1-3 months past due
|
53,477 | 43,610 | ||||||
3-12 months past due
|
49,200 | 54,522 | ||||||
1,852,334 | 1,552,471 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
2014
|
2013
|
|||||||
Opening balance
|
324,017 | 392,852 | ||||||
Impairment loss recognized
|
71,029 | 79,465 | ||||||
Acquisition through business combination
|
1,058 | - | ||||||
Effect of change in foreign exchange rate
|
(32,818 | ) | (70,731 | ) | ||||
Amounts written-off
|
(49,460 | ) | (77,569 | ) | ||||
Closing balance
|
313,826 | 324,017 |
2014
|
2013
|
|||||||
Cash and cash equivalents
|
3,894,898 | 3,808,708 | ||||||
Current liabilities
|
2,152,389 | 2,019,869 | ||||||
Current cash debt coverage ratio
|
181 | % | 189 | % |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
31 December 2014
|
31 December 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying
|
Contractual
|
6 months
|
6-12 | 1-2 | 2-5 |
More than 5
|
Carrying
|
Contractual
|
6 months
|
6-12 | 1-2 | 2-5 |
More than 5
|
|||||||||||||||||||||||||||||||||||||||||||
Amount
|
cash flows
|
or less
|
Months
|
years
|
years
|
Years
|
Amount
|
cash flows
|
or less
|
months
|
years
|
years
|
Years
|
|||||||||||||||||||||||||||||||||||||||||||
Non-derivative financial liabilities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secured bank loans
|
23,993 | (27,355 | ) | (22,045 | ) | (583 | ) | (1,115 | ) | (2,839 | ) | (773 | ) | 24,997 | (29,122 | ) | (789 | ) | (20,969 | ) | (1,474 | ) | (3,856 | ) | (2,034 | ) | ||||||||||||||||||||||||||||||
Unsecured bank loans
|
1,552,720 | (1,630,942 | ) | (559,525 | ) | (474,145 | ) | (339,873 | ) | (257,399 | ) | - | 1,515,310 | (1,589,578 | ) | (482,931 | ) | (353,497 | ) | (378,943 | ) | (374,207 | ) | - | ||||||||||||||||||||||||||||||||
Finance lease liabilities
|
17,861 | (21,127 | ) | (2,809 | ) | (27 | ) | (2,050 | ) | (6,116 | ) | (10,125 | ) | 21,094 | (25,294 | ) | (2,974 | ) | (245 | ) | (2,479 | ) | (6,582 | ) | (13,014 | ) | ||||||||||||||||||||||||||||||
Trade and other payables*
|
499,536 | (502,716 | ) | (502,716 | ) | - | - | - | - | 475,154 | (478,608 | ) | (474,462 | ) | - | (4,146 | ) | - | - | |||||||||||||||||||||||||||||||||||||
Bank overdraft
|
- | - | - | - | - | - | - | 237 | (237 | ) | (237 | ) | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
Due to related parties
|
10,624 | (10,645 | ) | (10,645 | ) | - | - | - | - | 42,278 | (42,300 | ) | (42,300 | ) | - | - | - | - | ||||||||||||||||||||||||||||||||||||||
Consideration payable in relation to acquisition of Belarusian Telecom
|
70,394 | (100,000 | ) | - | - | - | - | (100,000 | ) | 69,054 | (100,000 | ) | - | - | - | - | (100,000 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative financial liabilities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Option contracts
|
362 | (362 | ) | (362 | ) | - | - | - | - | 994 | (994 | ) | (994 | ) | - | - | - | - | ||||||||||||||||||||||||||||||||||||||
TOTAL
|
2,175,490 | (2,293,147 | ) | (1,098,102 | ) | (474,755 | ) | (343,038 | ) | (266,354 | ) | (110,898 | ) | 2,149,118 | (2,266,133 | ) | (1,004,687 | ) | (374,711 | ) | (387,042 | ) | (384,645 | ) | (115,048 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
31 December 2013
|
||||||||
USD
|
EUR
|
|||||||
Foreign currency denominated assets
|
||||||||
Other non-current assets
|
194 | 2,131 | ||||||
Due from related parties-current
|
3,263 | 87 | ||||||
Trade receivables and accrued income
|
25,538 | 38,506 | ||||||
Other current assets
|
8,298 | 3,399 | ||||||
Cash and cash equivalents
|
660,426 | 377 | ||||||
697,719 | 44,500 | |||||||
Foreign currency denominated liabilities
|
||||||||
Loans and borrowings-non current
|
(619,155 | ) | (15,764 | ) | ||||
Other non-current liabilities
|
(82,900 | ) | - | |||||
Loans and borrowings-current
|
(734,031 | ) | (14,010 | ) | ||||
Trade and other payables
|
(150,760 | ) | (19,194 | ) | ||||
Due to related parties
|
(188 | ) | (129 | ) | ||||
(1,587,034 | ) | (49,097 | ) | |||||
Net exposure
|
(889,315 | ) | (4,597 | ) | ||||
31 December 2014
|
||||||||
USD
|
EUR
|
|||||||
Foreign currency denominated assets
|
||||||||
Other non-current assets
|
57 | 2,131 | ||||||
Due from related parties-current
|
4,519 | 190 | ||||||
Trade receivables and accrued income
|
31,901 | 30,557 | ||||||
Other current assets
|
10,852 | 4,215 | ||||||
Cash and cash equivalents
|
1,556,596 | 4,466 | ||||||
1,603,925 | 41,559 | |||||||
Foreign currency denominated liabilities
|
||||||||
Loans and borrowings-non current
|
(362,578 | ) | (14,983 | ) | ||||
Other non-current liabilities
|
(88,021 | ) | - | |||||
Loans and borrowings-current
|
(990,122 | ) | (2,093 | ) | ||||
Trade and other payables
|
(139,005 | ) | (23,912 | ) | ||||
Due to related parties
|
(2,107 | ) | (3,390 | ) | ||||
(1,581,833 | ) | (44,378 | ) | |||||
Net exposure
|
22,092 | (2,819 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
Average Rate
|
Closing Rate
|
|||||||||||||||
31 December
|
31 December
|
31 December
|
31 December
|
|||||||||||||
2014
|
2013
|
2014
|
2013
|
|||||||||||||
USD/TL
|
2.1850 | 1.9094 | 2.3189 | 2.1343 | ||||||||||||
EUR/TL
|
2.9004 | 2.5390 | 2.8207 | 2.9365 | ||||||||||||
USD/BYR
|
10,255 | 8,883 | 11,850 | 9,510 | ||||||||||||
USD/UAH
|
11.8661 | 7.9930 | 15.7686 | 7.9930 |
Profit or loss
|
||||||||
2014
|
2013
|
|||||||
USD
|
(2,209 | ) | 88,932 | |||||
EUR
|
343 | 632 |
Profit or loss
|
||||||||
2014
|
2013
|
|||||||
USD
|
2,209 | (88,932 | ) | |||||
EUR
|
(343 | ) | (632 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
31 December 2014
|
31 December 2013
|
|||||||||||||||||||
Effective
|
Carrying
|
Effective
|
Carrying
|
|||||||||||||||||
Interest
|
interest
|
|||||||||||||||||||
Note
|
Rate
|
Amount
|
rate
|
Amount
|
||||||||||||||||
Fixed rate instruments
|
||||||||||||||||||||
Time deposits
|
22 | |||||||||||||||||||
USD
|
2.6 | % | 1,594,121 | 3.4 | % | 661,527 | ||||||||||||||
EUR
|
1.0 | % | 4,810 | 1.8 | % | 1,101 | ||||||||||||||
TL
|
11.2 | % | 2,030,463 | 9.9 | % | 2,922,068 | ||||||||||||||
Other
|
18.3 | % | 15,684 | 5.0 | % | 16,851 | ||||||||||||||
Held-to-maturity securities
|
17 | |||||||||||||||||||
Corporate securities TL
|
10.1 | % | 1,279 | 10.7 | % | 23,204 | ||||||||||||||
Finance lease obligations
|
26 | |||||||||||||||||||
USD
|
2.2 | % | (316 | ) | 1.6 | % | (769 | ) | ||||||||||||
EUR
|
3.4 | % | (17,545 | ) | 3.4 | % | (20,325 | ) | ||||||||||||
Unsecured bank loans
|
26 | |||||||||||||||||||
USD fixed rate loans
|
6.0 | % | (121,246 | ) | 5.0 | % | (223,052 | ) | ||||||||||||
TL fixed rate loans
|
9.8 | % | (204,704 | ) | 9.9 | % | (153,942 | ) | ||||||||||||
Secured bank loans
|
26 | |||||||||||||||||||
BYR fixed rate loans
|
11.9 | % | (4,106 | ) | 11.9 | % | (6,042 | ) | ||||||||||||
Restricted cash
|
21 | |||||||||||||||||||
TL
|
- | - | 6.5 | % | 43,078 | |||||||||||||||
Variable rate instruments
|
||||||||||||||||||||
Held-to-maturity securities
|
17 | |||||||||||||||||||
Corporate securities TL
|
12.1 | % | 3,553 | 11.3 | % | 7,675 | ||||||||||||||
Secured bank loans
|
26 | |||||||||||||||||||
USD floating rate loans
|
6.3 | % | (19,887 | ) | 7.5 | % | (18,955 | ) | ||||||||||||
Unsecured bank loans
|
26 | |||||||||||||||||||
USD floating rate loans
|
2.1 | % | (1,226,770 | ) | 2.8 | % | (1,138,316 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
Profit or loss
|
Equity
|
|||||||||||||||
100 bp increase
|
100 bp decrease
|
100 bp increase
|
100 bp decrease
|
|||||||||||||
31 December 2014
|
||||||||||||||||
Variable rate instruments
|
(4,154 | ) | 4,154 | - | - | |||||||||||
Cash flow sensitivity (net)
|
(4,154 | ) | 4,154 | - | - | |||||||||||
31 December 2013
|
||||||||||||||||
Variable rate instruments
|
(5,540 | ) | 5,540 | - | - | |||||||||||
Cash flow sensitivity (net)
|
(5,540 | ) | 5,540 | - | - | |||||||||||
Fair values
|
|||||||
31 December 2014
|
31 December 2013
|
Fair Value hierarchy
|
Valuation Techniques
|
||||
Option contracts used for hedging
|
(362)
|
(994)
|
Level 2
|
Quoted bid prices in financial institutions
|
|||
Consideration payable in relation to acquisition of Belarusian Telecom
|
(70,394)
|
(69,054)
|
Level 3
|
Net present value (*)
|
|||
(*)
|
Discount rate of 5.0% used for the present value calculation for the consideration payable in relation to acquisition of Belarusian Telecom as of 31 December 2014 (31 December 2013: 6.1%).
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
31 December 2014
|
31 December 2013
|
|||||||||||||||||||
Carrying
|
Fair
|
Carrying
|
Fair
|
|||||||||||||||||
Note
|
Amount
|
Value
|
Amount
|
Value
|
||||||||||||||||
Assets carried at amortized cost
|
||||||||||||||||||||
Other non-current assets**
|
18 | 4,216 | 4,216 | - | - | |||||||||||||||
Due from related parties-short term
|
35 | 5,579 | 5,579 | 10,012 | 10,012 | |||||||||||||||
Trade receivables and accrued income*
|
20 | 1,846,755 | 1,846,755 | 1,542,459 | 1,542,459 | |||||||||||||||
Other current assets**
|
21 | 17,825 | 17,825 | 58,750 | 58,750 | |||||||||||||||
Held-to-maturity
|
17 | 4,832 | 4,832 | 30,879 | 30,879 | |||||||||||||||
Available for sale
|
17 | 3,512 | 3,512 | |||||||||||||||||
Cash and cash equivalents***
|
22 | 3,894,898 | 3,894,898 | 3,808,708 | 3,808,708 | |||||||||||||||
5,777,617 | 5,777,617 | 5,450,808 | 5,450,808 | |||||||||||||||||
Liabilities carried at amortized cost
|
||||||||||||||||||||
Loans and borrowings-long term
|
26 | (538,128 | ) | (538,128 | ) | (716,150 | ) | (716,150 | ) | |||||||||||
Bank overdrafts
|
22 | - | - | (237 | ) | (237 | ) | |||||||||||||
Loans and borrowings-short term
|
26 | (1,056,446 | ) | (1,056,446 | ) | (845,251 | ) | (845,251 | ) | |||||||||||
Trade and other payables****
|
30 | (499,536 | ) | (499,536 | ) | (475,154 | ) | (475,154 | ) | |||||||||||
Due to related parties
|
35 | (10,624 | ) | (10,624 | ) | (42,278 | ) | (42,278 | ) | |||||||||||
(2,104,734 | ) | (2,104,734 | ) | (2,079,070 | ) | (2,079,070 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
31.
|
Financial instruments (continued)
|
2014
|
2013
|
|||||||
Opening balance
|
69,054 | 76,413 | ||||||
Total gains or losses:
|
||||||||
in profit or loss
|
1,340 | (7,359 | ) | |||||
Closing balance
|
70,394 | 69,054 |
32.
|
Operating leases
|
2014
|
2013
|
|||||||
Less than one year
|
55,561 | 38,001 | ||||||
Between one and five years
|
51,129 | 44,079 | ||||||
More than five years
|
7,493 | 8,320 | ||||||
114,183 | 90,400 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
32.
|
Operating leases (continued)
|
2014
|
2013
|
2012
|
||||||||||
Minimum lease payments
|
262,692 | 323,019 | 313,443 | |||||||||
Contingent lease payments
|
1,303 | - | - | |||||||||
Total
|
263,995 | 323,019 | 313,443 |
33.
|
Guarantees and purchase obligations
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
2014
|
2013
|
|||||||
Contingent liabilities incurred by the Group arising from its interests in A-tel
|
- | - | ||||||
Contingent liabilities incurred by the Group arising from its interests in Fintur
|
- | - | ||||||
Group’s share of Fintur’s contingent liabilities
|
475 | 37,101 | ||||||
Group’s share of A-tel’s contingent liabilities
|
- | - | ||||||
475 | 37,101 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
34.
|
Commitments and Contingencies (continued)
|
35.
|
Related parties
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
35.
|
Related parties (continued)
|
Due from related parties – short term
|
2014
|
2013
|
||||||
KVK Teknoloji Urunleri AS (“KVK Teknoloji”)
|
2,546 | 622 | ||||||
Vimpelcom OJSC (“Vimpelcom”)
|
808 | 1,570 | ||||||
Megafon OJSC (“Megafon”)
|
504 | 439 | ||||||
GSM Kazakhstan Ltd (“Kazakcell”)
|
489 | 700 | ||||||
Krea Icerik Hizmetleri ve Produksiyon AS (“Krea”)
|
429 | 1,378 | ||||||
Kyivstar GSM JSC (“Kyivstar”)
|
2 | 268 | ||||||
T-Medya
|
- | 2,979 | ||||||
Other
|
801 | 2,056 | ||||||
5,579 | 10,012 |
Due to related parties – short term
|
2014
|
2013
|
||||||
KVK Teknoloji Urunleri AS (“KVK Teknoloji”)
|
4,058 | 2,847 | ||||||
Hobim Bilgi Islem Hizmetleri AS (“Hobim”)
|
3,049 | 3,535 | ||||||
Krea Icerik Hizmetleri ve Produksiyon AS (“Krea”)
|
1,505 | 362 | ||||||
A-Tel
|
- | 32,212 | ||||||
Other
|
2,012 | 3,322 | ||||||
10,624 | 42,278 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
35.
|
Related parties (continued)
|
Revenue from related parties
|
2014
|
2013
|
2012
|
||||
Sales to KVK Teknoloji
|
|||||||
Simcard and prepaid card sales
|
196,432
|
303,796
|
395,859
|
||||
Sales to Kyivstar
|
|||||||
Telecommunications services
|
31,779
|
49,301
|
47,316
|
||||
Sales to Vimpelcom
|
|||||||
Telecommunications services
|
22,162
|
15,883
|
11,292
|
||||
Sales to Megafon
|
|||||||
Telecommunication services
|
14,016
|
10,117
|
5,454
|
||||
Sales to Teliasonera International
|
|||||||
Telecommunications services
|
8,244
|
6,806
|
6,434
|
||||
Sales to Millenicom Telekomunikasyon AS (“Millenicom”)
|
|||||||
Telecommunications services
|
5,014
|
5,834
|
4,992
|
||||
Sales to Krea
|
|||||||
Call center revenues, fixed line services, rent and interest charges
|
4,925
|
8,842
|
11,440
|
||||
Sales to A-Tel
|
|||||||
Simcard and prepaid card sales
|
-
|
-
|
5,660
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
35.
|
Related parties (continued)
|
Related party expenses
|
2014
|
2013
|
2012
|
|||
Charges from KVK Teknoloji
|
||||||
Dealer activation fees and others
|
51,616
|
39,925
|
20,078
|
|||
Charges from Kyivstar
|
||||||
Telecommunications services
|
31,993
|
44,515
|
40,511
|
|||
Charges from Hobim
|
||||||
Invoicing and archieving services
|
16,529
|
21,994
|
22,630
|
|||
Charges from Teliasonera International
|
||||||
Telecommunications services
|
6,964
|
8,665
|
8,302
|
|||
Charges from Vimpelcom
|
||||||
Telecommunications services
|
6,263
|
6,765
|
5,986
|
|||
Charges from Krea
|
||||||
Digital television broadcasting services
|
5,936
|
4,863
|
9,130
|
|||
Charges from Megafon
|
||||||
Telecommunications services
|
5,822
|
7,787
|
4,498
|
|||
Charges from Millenicom
|
||||||
Telecommunications services
|
3,433
|
3,693
|
4,261
|
|||
Charges from A-Tel (*)
|
||||||
Dealer activation fees and others
|
-
|
-
|
32,561
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
35.
|
Related parties (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
35.
|
Related parties (continued)
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
36.
|
Subsidiaries
|
Effective Ownership Interest
|
||||
Subsidiaries
|
Country of
|
31 December
|
31 December
|
|
Name
|
Incorporation
|
Business
|
2014 (%)
|
2013 (%)
|
Kibris Telekom
|
Turkish Republic of Northern Cyprus
|
Telecommunications
|
100
|
100
|
Global Bilgi Pazarlama Danışma ve Cagri Servisi Hizmetleri AS
|
Turkey
|
Customer relations management
|
100
|
100
|
Turktell Bilisim Servisleri AS
|
Turkey
|
Information technology, value added GSM services investments
|
100
|
100
|
Turkcell Superonline
|
Turkey
|
Telecommunications
|
100
|
100
|
Turkcell Satis ve Dagitim Hizmetleri AS
|
Turkey
|
Telecommunications
|
100
|
100
|
Eastasia
|
Netherlands
|
Telecommunications investments
|
100
|
100
|
Turkcell Teknoloji Arastirma ve Gelistirme AS
|
Turkey
|
Research and Development
|
100
|
100
|
Kule Hizmet ve Isletmecilik AS
|
Turkey
|
Telecommunications infrastructure business
|
100
|
100
|
Turkcell Interaktif Dijital Platform ve Icerik Hizmetleri AS
|
Turkey
|
Radio and television broadcasting
|
100
|
100
|
Financell
|
Netherlands
|
Financing business
|
100
|
100
|
Rehberlik Hizmetleri Servisi AS
|
Turkey
|
Telecommunications
|
100
|
100
|
Beltur Coöperatief U.A.
|
Netherlands
|
Telecommunications investments
|
100
|
100
|
Beltel
|
Turkey
|
Telecommunications investments
|
100
|
100
|
Turkcell Gayrimenkul Hizmetleri AS
|
Turkey
|
Property investments
|
100
|
100
|
Global LLC
|
Ukraine
|
Customer relations management
|
100
|
100
|
UkrTower
|
Ukraine
|
Telecommunications infrastructure business
|
100
|
100
|
Turkcell Europe GmbH
|
Germany
|
Telecommunications
|
100
|
100
|
Global Odeme Sistemleri AS
|
Turkey
|
GSM services
|
100
|
100
|
Belarusian Telecom
|
Republic of Belarus
|
Telecommunications
|
80
|
80
|
Lifetech LLC
|
Republic of Belarus
|
Research and Development
|
78
|
78
|
Inteltek
|
Turkey
|
Betting business
|
55
|
55
|
Euroasia
|
Netherlands
|
Telecommunications
|
55
|
55
|
Astelit
|
Ukraine
|
Telecommunications
|
55
|
55
|
Azerinteltek
|
Azerbaijan
|
Betting Business
|
28
|
28
|
Turktell Uluslararasi Yatırım Holding AS**
|
Turkey
|
Telecommunications investments
|
-
|
100
|
Global FLLC *
|
Republic of Belarus
|
Customer relations management
|
-
|
100
|
Talih Kusu Altyapi Hizmetleri AS***
|
Turkey
|
Telecommunications investments
|
-
|
100
|
Fizy Iletisim AS****
|
Turkey
|
Music and video broadcasting
|
-
|
70
|
*
|
It has been decided to liquidate Global FLLC on 28 November 2013. The liquidation has been completed as at 9 October 2014.
|
**
|
Turktell Uluslararası Yatrım Holding AS is entirely acquired by Turkcell and the process has been completed by 24 December 2014.
|
***
|
Talihkusu Alt Yapi Hizmetleri AS is entirely acquired by Turkcell Superonline and the process has been completed by 18 December 2014.
|
****
|
Fizy is entirely acquired by Turktell Bilisim Servisleri AS and the process has been completed by 18 December 2014.
|
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
36.
|
Subsidiaries (continued)
|
Name of subsidiary
|
Place of
incorporation
and principal
place of business
|
Proportion of ownership
interests and voting rights held by non-controlling interest
|
Profit / (loss) allocated to
non-controlling interests
|
Accumulated non-controlling interests
|
|||||||||||||||||||||
31 December
2014
|
31 December
2013
|
31 December
2014
|
31 December
2013
|
31 December
2014
|
31 December
2013
|
||||||||||||||||||||
Eurasia
|
Netherlands/Ukraine
|
44.96 | 44.96 | (217,753 | ) | (14,710 | ) | (218,557 | ) | (121,101 | ) | ||||||||||||||
Inteltek
|
Turkey
|
45.00 | 45.00 | 16,507 | 13,563 | 49,500 | 36,855 | ||||||||||||||||||
Individually immaterial
non-controlling interestsubsidiaries with |
|
6,907 | 2,423 | 3,989 | (809 | ) | |||||||||||||||||||
(194,339 | ) | 1,276 | (165,068 | ) | (85,055 | ) |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
36.
|
Subsidiaries (continued)
|
31 December
|
31 December
|
|||||||||||
2014
|
2013
|
|||||||||||
Current assets
|
46,655 | 36,235 | ||||||||||
Non-current assets
|
203,393 | 441,451 | ||||||||||
Current liabilities
|
740,787 | 746,182 | ||||||||||
Non-current liabilities
|
5,467 | 11,784 | ||||||||||
Deficit in equity
|
(496,206 | ) | (280,280 | ) | ||||||||
2014
|
2013 | 2012 | ||||||||||
Revenue
|
347,183 | 449,796 | 405,417 | |||||||||
Expenses
|
(831,508 | ) | (482,515 | ) | (461,485 | ) | ||||||
Loss for the year
|
(484,325 | ) | (32,719 | ) | (56,068 | ) | ||||||
|
||||||||||||
Other comprehensive income / (loss) for the year
|
268,399 | - | (65 | ) | ||||||||
Net cash inflow from operating activities
|
68,601 | 76,382 | 116,870 | |||||||||
Net cash outflow from investing activities
|
(42,601 | ) | (65,298 | ) | (79,203 | ) | ||||||
Net cash inflow / (outflow) from financing activities
|
(5,000 | ) | (46,450 | ) | 1,078 | |||||||
Effects of foreign exchange rate fluctuations on
|
||||||||||||
cash and cash equivalents
|
(12,093 | ) | 13 | (14 | ) | |||||||
Net cash inflow / (outflow)
|
8,907 | (35,353 | ) | 38,731 |
TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
As at and for the year ended 31 December 2014
|
(Amounts expressed in thousands of US Dollars unless otherwise indicated except share amounts)
|
(The Group’s audited consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 were approved by the Audit Committee and the Board of Directors (Board Resolution dated 23 February 2011 and numbered 797, dated 22 February 2012 and numbered 908, dated 21 February 2013 and numbered 1019 and dated 19 February 2014 and numbered 1106, respectively). However, consolidated financial statements prepared as at and for the year ended 31 December 2010 were not approved by the General Assemblies on 21 April 2011, 11 August 2011 and 12 October 2011. The General Assemblies on 29 June 2012, 22 May 2013, 24 June 2013 and 29 May 2014 could not convene since the quorum required had not been reached and the consolidated financial statements prepared as at and for the year ended 31 December 2010, 2011, 2012 and 2013 could not be presented for approval.)
|
36.
|
Subsidiaries (continued)
|
31 December
|
31 December
|
|||||||
2014
|
2013
|
|||||||
Current assets
|
130,973 | 99,794 | ||||||
Non-current assets
|
10,560 | 13,849 | ||||||
Current liabilities
|
12,267 | 13,050 | ||||||
Non-current liabilities
|
19,265 | 18,694 | ||||||
Equity
|
110,001 | 81,899 |
2014
|
2013
|
2012
|
||||||||||
Revenue
|
58,297 | 56,539 | 51,771 | |||||||||
Expenses
|
(21,614 | ) | (26,398 | ) | (22,890 | ) | ||||||
Profit for the year
|
36,683 | 30,141 | 28,881 | |||||||||
|
||||||||||||
Other comprehensive (expense) / income for the year
|
(8,578 | ) | (13,977 | ) | 3,235 | |||||||
Net cash inflow from operating activities
|
19,648 | 16,487 | 30,713 | |||||||||
Net cash inflow from investing activities
|
13,899 | 3,238 | 11,715 | |||||||||
Net cash outflow from financing activities
|
- | (1,123 | ) | (19,250 | ) | |||||||
Effects of foreign exchange rate fluctuations on cash
and cash equivalents
|
1,251 | 2,691 | (588 | ) | ||||||||
Net cash inflow
|
34,798 | 21,293 | 22,590 |
37.
|
Subsequent events
|
TURKCELL ILETISIM HIZMETLERI A.S.
|
|||
Date: February 13, 2015
|
By:
|
/s/ Murat Dogan Erden
|
|
Name:
|
Murat Dogan Erden
|
||
Title:
|
Chief Financial Officer
|
TURKCELL ILETISIM HIZMETLERI A.S.
|
|||
Date: February 13, 2015
|
By:
|
/s/ Nihat Narin
|
|
Name:
|
Nihat Narin
|
||
Title:
|
Investor Relations Director
|